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INTRODUCTION
The basis of evolutionary processes resides
in the dynamic nature of genetic material: novel
DNA sequences are continually being produced by
mutation and recombination. Through the
stabilization and transmission of these genetic
products, evolutionary directions are
established. Vertical transmission, the
transfer of genes from parents to offspring, is
most generally thought to determine these
directions. However, it is becoming
increasingly apparent that another form of
transmission, horizontal transfer, contributes
greatly to evolutionary processes in a wide
variety of organisms.
Horizontal gene transfer refers to the
mobilization and stabilization of genetic
information from one organism to another.
Such
exchange is a well-established phenomenon in the
prokaryotic kingdom. Among bacteria,
genetically plastic transmissible elements are
mobilized into host organisms, where
modifications and further radial transfer can
occur. Mobilization primarily involves
extrachromosomal elements, many of which encode
systems for their own transfer. (Emphasis
added.) (From Bacterial Plasmids and Gene Flux
( 2) • )

This dissertation project has sought to elucidate
the mechanism of horizontal gene transfer of pLV22a, a 4.2
kb plasmid isolated from Bacteroides fragilis strain LV22.
The project is comprised of 5 main areas of investigation.
In the first part of the project, pLV22a was captured by
the E. coli-Bacteroides shuttle plasmid pGAT400•BglII in a
series of experiments designed to investigate multiple
transfer factors native to strain LV22.

Fusion of these 2
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plasmids resulted in a conjugatively transferable
phenotype (i.e., transferable by a conjugation-type
mechanism).
that:

The second line of investigation demonstrated

pLV22a can transfer independently in B.

(g)

(b) pLV22a can transfer in Escherichia coli,

fragilis;

when co-resident with the broad-host-range conjugal (i.e.,
self-transferable) IncPB plasmid R751.
The third line of investigation sought to define the
region required for pLV22a transfer in E. coli through the
use of TnlOOO transposon mutagenesis. A 1.5 kb region was
identified, and its nucleotide sequence determined.
The fourth area of investigation identified, using
computer analysis, five open reading frames of greater
than 10 kDa; 3 in the •top' strand, and 2 in the 'bottom'
strand.

Complementation analysis was then applied to

determine which of the 3 top-strand open reading frames
were required for transfer in E.coli.

All 3 open reading

frames were found to be independently expressed and
necessary for transfer.
The fifth line of research utilized sequence and
complementation analyses to localize the cis-acting pLV22a
origin of transfer (oriT) to a region within the 1.5 kb
transfer region.

(The oriT is the point at which one

strand of DNA is specifically nicked in preparation for
transfer.)

Using the polymerase chain reaction and

complementation analysis, the oriT region was cloned, and
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subsequently found to confer transferability to a
transfer-deficient E. coli vector.

CHAPTER 2
LITERATURE REVIEW

Physical Characteristics of Members of the Genus

Bacteroides
Bacteroides are obligate anaerobic gram negative rod
bacteria (98).

Bacteroides require anaerobic conditions

for growth, but are also highly aerotolerant, and can
survive prolonged exposure to oxygen.

They are found in

high concentrations in the colon of both humans and
animals.

Members of the genus include B. fragilis,

Bacteroides caccae, Bacteroides distasonis, Bacteroides
eggerthii, Bacteroides merdae, Bacteroides ovatus,
Bacteroides stercoris, Bacteroides thetaiotaomicron,
Bacteroides uniformis and Bacteroides vulgatus (97).
Bacteroides are highly saccharolytic organisms.

In

the gut, most mono- and disaccharides are efficiently
absorbed in the small intestine, and do not reach the
colon, where Bacteroides are found (85).

Nevertheless,

these organisms are able to flourish by hydrolyzing a
variety of complex polysaccharides from both host-ingested
plant material and host secretions (87).

Some of the

enzymes involved in polysaccharide degradation include
4
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neuraminidase, a-glucosidase, B-glucosidase, afucosidase, a-N-acetylgalactosaminidase, B-Nacetylglucosaminidase, a-galactosidase, B-galactosidase,
chondroitin lyase I, and chondroitin lyase II
(6,33,38,52).

The majority of these enzymes have been

found to be associated with the outer membrane and
periplasm, while others are cytosolic in nature.

In the

laboratory, most Bacteroides grow readily on a simple
defined medium which consists of a fermentable
carbohydrate, a source of nitrogen such as ammonium
sulfate, vitamin B12 , heroin, inorganic ions and cysteine
(as a reductant).

Growth rates are about 0.33-1

generation per hour (85).

The pathways used by

Bacteroides in the metabolism of absorbed carbohydrates

have not been fully defined, but include Embden-Meyerhof
glucose fermentation, (53), a glucose--> succinate
metabolic pathway (98), and possibly a pentose phosphatehexose monophosphate shunt pathway (99).
Bacteroides cannot use amino acids or proteins as the

sole source of carbon or energy, nor do they require amino
acids or peptides when grown on carbohydrates (85).
Nevertheless, several Bacteroides extracellular peptidases
have been identified.

Gibson et al. have characterized 3

major proteases in a strain of B. fragilis.

Pl is a

serine protease, and is located intracellularly and in the
periplasm.

P2, a metalloprotease, and P3, a cysteine
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protease, are located in the outer membrane (32).

The

activity of these proteases was found to progressively
transfer into the culture medium during stationary phase.
Whether this transfer represented active enzyme secretion
or simple cell degradation was not determined (31).

In a

study of proteolytic gut bacteria, they found Bacteroides
to be well represented (51).
Since protein catabolism is not required for growth,
the protease production found in Bacteroides is
intriguing.

The ability to use both carbohydrates and

peptides for protein and lipid synthesis may give an
advantage to these organisms in the colon, where host
dietary intake is in constant flux.

For example, Smith

and Salyers have found that B. thetaiotaomicron can ingest
amino acids and incorporate them de novo into proteins and
lipids (110).

Bacteroides proteases may also be involved

in the pathogenesis of these organisms, as discussed in

Miscellaneous Virulence Factors (Chapter 2).
Epidemiology
Bacteroides are the predominant anaerobes in the
human gut (93), and account for approximately 21% of all
colonic isolates (58).

As such, they are considered to be

important contributors to the maintenance of the colonic
ecosystem.

Bacteroides produce fermentation products that

serve as nutrients for other colonic microflora as well as
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the host {85), and may also contribute to colonic dietary
fiber digestion {86).
While Bacteroides play a prominent role in the
colonic ecosystem of their host, they frequently become
opportunistic pathogens when released into the surrounding
tissues.

They are the predominant anaerobic isolates from

abdominal infections, skin and subcutaneous wounds, and
abscesses proximal to the rectum {13).

The reason for the

frequent appearance of Bacteroides in these infections may
be due in part to their high concentration in the colon.
However, virulence factors also play a significant role in
their pathogenicity {see Virulence Factors, Chapter 2).

A

retrospective study by Brook on the distribution of
different Bacteroides species in clinical isolates over a
12 year period at Walter Reed Army Medical Center in
Washington, DC and the Navy Hospital in Bethesda, MD drew
several conclusions {12).

Among them, out of 15844

bacterial cultures collected from patients at these 2
hospitals in the 12 year period, Bacteroides were isolated
from 19% of them.

B. fragilis accounted for 63% of all

Bacteroides isolates; B. thetaiotaomicron for 14%; B.
vulgatus and B. ovatus for 7% each; B. distasonis for 6%;
and B. uniformis for 2%.

Of the five major foci for

Bacteroides infection, B. fragilis was isolated with the
greatest frequency: 78% of all Bacteroides species from
blood cultures, 69% from wounds, 65% from abscesses, 59%
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from abdominal infections, and 56% from pelvic infections.
Members of the genus were also regularly isolated from
chest and genitourinary tract infections, cysts, bile, and
tumors.

Bacteroides septicemia (i.e., persistent invasion

of the blood stream by bacteria) frequently had an
unfavorable outcome, with an overall mortality of 24%
(14).

Infections involving Bacteroides are often
polymicrobial in nature.

In addition to Bacteroides,

rectal abscesses also regularly contain Staphylococcus
aureus, streptococcus pyogenes, or Enterobacteriaceae

(especially E.coli).

Likewise, abdominal abscesses

containing Bacteroides frequently also contain E. coli or
other Enterobacteriaceae (13).

An exception to this is in

Bacteroides septicemia, where infections can be poly- or

monomicrobial (14,19).

Although the organisms co-isolated

with Bacteroides are usually a part of the normal
microflora surrounding the infection foci, their
appearance along with Bacteroides is probably not
coincidental.

Synergy between Bacteroides and E. coli,

Klebsiella pneumoniae, Pseudomonas aeruginosa, s. aureus,
S. pyogenes, and enterococci has been noted.

In vivo

studies using murine models have found that this synergy
can lead to a lowered Lethal Dose 50 (16), an enhanced
ability to form abscesses (15,16), an induction of at
least 1 Bacteroides virulence factor (i.e., capsule
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formation)

(15) and an increase in the survival of

organisms in abscesses (11).
Bacteroides possess a wide array of tools with which
they cause and maintain infections.

These include

virulence factors, antibiotic resistance mechanisms, and
horizontal gene transfer factors.
virulence Factors
A virulence factor is defined as a bacterial
attribute or product that provides the organism with a
selective advantage for establishing infection or ensuring
its own reproduction (44).

Known or putative bacterial

virulence factors include extracellular capsules,
fimbriae, outer membrane proteins, lipopolysaccharides,
proteases, nucleases and other enzymes, metabolites and
exotoxins.

Bacteroides possess both confirmed and

putative virulence factors.

Extracellular capsule.

Perhaps the best-studied

Bacteroides virulence factor is their extracellular
mucopolysaccharide capsule, common to all Bacteroides
species with the possible exception of B. distasonis
(3,15).

The capsule is not a homogenous entity, showing

variation at the species and strain levels.

Pantosti et

al. have identified 2 antigenically distinct capsular
polysaccharides in a single B. fragilis strain,
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polysaccharide A and polysaccharide B, while Patrick et
al. have classified large-capsule, small-capsule and
electron-dense capsule populations in different B.

fragilis strains (50,72,73,116).

B. thetaiotaomicron and

B. vulgatus isolates possessing unique capsule
configurations have also been identified.

These isolates

displayed numerous strands of polysaccharide extending
from the cell surface, and were highly resistant to hostmediated killing (7).
Capsule formation is induced by unknown signals
present in vivo: animal passage leads to increased
encapsulation, as does co-infection with aerobic bacteria.
Conversely, serial subculture reduces capsular expression
(15,108).

In vivo, the capsule appears to enhance

infectivity, since intraperitoneal injections of
encapsulated B. fragilis strains alone produce abscesses
in rats, while unencapsulated strains usually require coinfection with aerobic bacteria (64).

The capsule itself

is a causative agent, since capsule material alone can
stimulate intra-abdominal abscess formation in rats (64).
Capsules also influence the host-mediated response to

Bacteroides infection.

Unencapsulated strains have

increased susceptibility to host-mediated opsonophagocytic
killing (80,108), and Bacteroides capsular preparations
alone can inhibit polymorphonuclear leukocyte metabolism,
chemotaxis (27), and phagocytosis (119).

Capsule
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preparations also confer immunity to subsequent

Bacteroides challenge (100).

Adhesion of bacterial cells to host surfaces (ce11ce11 interactions).

Adhesion of gram-negative bacteria to

mucosal surfaces, resulting in enhanced bacterial
retention and thus infectivity, is generally associated
with fimbriae (44).

Pruzzo et al. found that B. fragilis

fimbriae increased non-specific bacterial cell adherence
to both epithelial cells and neutrophils, which in turn
led to increased phagocytosis by the latter (75,76).

The

net contribution of these structures upon the virulence of

B. fragilis is consequently unclear.

Oyston and Handley

reported that the capsule itself may play a significant
role in Bacteroides adhesion (66), while Guzman et al.
have established that 48% of B. fragilis clinical isolates
studied possessed a neuraminidase-dependent adhesin that
promoted attachment to mammalian epithelial cells, but not
human polymorphonuclear leukocytes (40).

since B.

fragilis produces neuraminidase, this adhesin may be
physiologically important for cell-cell attachment
(33,52).

Toxins.

While B. fragilis contains

lipopolysaccharide (LPS) in its cell wall, the LPS has a
low endotoxic activity when compared with enterobacterial
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LPS (121).

While not toxic, Zaleznik et al. found that B.

fragilis LPS is a potent abscess inducer, and thus can be
classified as a virulence factor (125).

Bacteroides do produce exotoxins.

Weikel et al.

reported that B. fragilis isolates from patients
exhibiting diarrhea were enterotoxigenic (120).

In

separate studies, Pantosti et al. and Van Tassell et al.
demonstrated that human and animal clinical isolates of B.

fragilis frequently produced exotoxins that were both
entero- and cytotoxic (71,118).

Miscellaneous virulence factors.

other factors which

may contribute to Bacteroides virulence include: (~)
succinic acid, a metabolic by-product of Bacteroides
glucose catabolism.

In vitro, succinic acid inhibited

polymorphonuclear leukocytes in a system that mimicked
conditions found in clinical abscesses.

Killing of E.

coli was eliminated, and both random migration and
directed chemotaxis of leukocytes was impaired (82,83).
(~) Farias et al. reported a strain of B. fragilis that
produced 2 bacteriocidal proteins.

These proteins, termed

fragilisins, could give strains producing them a
competitive advantage during pathogenesis (26).

(~)

McGregor et al. showed that many clinical isolates of B.

fragilis and B. thetaiotaomicron produced phospholipase
This enzyme hydrolyzes lecithin, a cell membrane

c.

13

component, and may contribute to host tissue damage and
enhance bacterial invasiveness (55).

(~) The production

of proteases have already been discussed in conjunction
with Bacteroides metabolism.

Bacteroides do not require

amino acids for growth, yet produce many proteases.
Proteases are likely virulence factor candidates, as they
have the potential to degrade a variety of host proteins
important in defense and cell wall assembly. In one case,
a metalloprotease has been found to be enterotoxigenic
(57) .

(~) Iron-repressible outer membrane proteins

(IROMPs).

Iron is necessary for bacterial growth, and

must be collected from the extracellular environment.
IROMPs are present in the-outer membranes of B. fragilis
grown in iron-poor media (44,65), and may give Bacteroides
a competitive advantage over other bacteria in the ironpoor milieu of the colon.

Antibiotic Resistance Mechanisms
The aforementioned virulence factors act together
coordinately to increase the pathogenicity of Bacteroides
throughout the course of an infection.

In contrast,

antibiotic resistance, while adding to the overall
virulence of an organism, typically does not come into
play until an infection has been established and treatment
initiated.

(An exception to this may be the intermittent

exposure to "naturally" produced antibiotics, such as
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penicillin and streptomycin.) Thus, while being
intrinsically different from other virulence factors,
antibiotic resistance does influence the final outcome of
an infection (46).

Bacteroides are universally resistant to
aminoglycosides (17).

Most strains are also resistant to

tetracycline, and most B-lactam drugs including the
penicillins and many cephalosporins (13,86).

In addition,

Garcia-Rodriguez et al. found varying levels of resistance
to cefoxitin (2-63 %), clindamycin (0-34%), and
piperacillin (12-21 %) in a recent, retrospective worldwide survey.

Chloramphenicol, while no longer generally

used to treat Bacteroides infections due to its potential
for toxicity, was nevertheless found active against most
clinical isolates (30).

Imipenem and metronidazole, along

with B lactam/B lactamase inhibitor combinations (e.g.,
amoxicillin/clavulanic acid, ampicillin/sulbactam,
ticarcillin/clavulanate and piperacillin/tazobactam) are
thus considered the best therapeutic choices for the
treatment of Bacteroides infections.
The antibiotic resistance mechanisms found in

Bacteroides vary widely according to the class of drug
under consideration.

Aminoglycoside resistance is due to

a lack of drug transport into the cell (17).

Resistance

to penicillins/cephalosporins is primarily mediated
through the production of a variety of B-lactamases
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(47,63,114), while ribosomal protection mechanisms account
for clindamycin (78) and tetracycline (61) resistance.

Horizontal Gene Transfer Factors
Many bacterial plasmids, and occasionally chromosomal
factors, are transferable to adjacent cells by a mating
process collectively known as conjugation.

These transfer

factors often carry antibiotic resistance genes, and thus
can account for the rapid conversion of an antibioticsensitive bacterial population to a resistant one.
Examples of Bacteroides transferable resistance factors
are: pBFTMl0 ( 15 kb) ( 113) , pBF4 ( 41 kb)

( 105) , and pBI136

(82 kb) (109), all of which bear clindamycin resistance
genes on related mobile DNA elements; pRYC3373 (40 kb)
which carries a chloramphenicol resistance gene (54); the
family of chromosomal factors known as Tet Elements (70200 kb), which carry tetracycline resistance genes, with
or without closely linked erythromycin resistance genes
(4,102).

B. fragilis strain TAL4170 (22), and B.

thetaiotaomicron UNl0l (77), also appear to possess
chromosomal cefoxitin resistance transfer factors.
Some conjugative (i.e., transferable by a
conjugation-type mechanism) factors appear to carry no
adventitious genes, and are termed cryptic.

While the

functions of cryptic transfer factors in Bacteroides are
unknown, their widespread occurrence suggests they do play

16
a role in horizontal gene transfer.

Cryptic transfer

factors may carry genes that confer a growth advantage
only in specific environments, and have the potential to
act in conjunction with mobile DNA elements to acquire and
then transfer new adventitious genes.

Among the

characterized Bacteroides cryptic transfer factors are
XBU4422, a 65 kb chromosomal element related to the Tet
Elements (107), the plasmids pBB-51 (4 kb)

(104,117), and

pBI143 (3 kb) (48), and the chromosomal insertion elements
NBUl and NBU2 (10-12 kb) (48,106).

A cryptic transposon,

Tn4399 (10 kb), has also been described (42,43,59).
Conjugative transfer of DNA is a multi-step process
that requires many functions including mating pair
formation and maintenance, and DNA processing in both the
host and recipient cells (28,124).

In the case of large

transferable plasmids such as F and R751 from the family
Enterobacteriaceae, most of these functions are supplied
by the plasmid, and they are referred to as conjugal or

self-transferable plasmids.

In contrast, small plasmids

like ColEl from E.coli perform only minimal DNA
processing, while other required functions are provided by
a co-resident conjugal plasmid.

These small plasmids are

referred to as mobilizable plasmids, and cannot transfer
unassisted.

Mobilization may thus be seen as a process in

which the mobilized plasmid fortuitously uses the
conjugation system of the co-resident conjugal plasmid.
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Both conjugal and mobilizable plasmids that have been
characterized possess 2 components absolutely required for
transfer: a cis-acting region of DNA known as the origin
of transfer (oriT), and 1 or more trans-acting DNA
processing proteins, including a

DNA relaxase.

Relaxases

bind at their cognate oriT, and then specifically cleave 1
strand of DNA at a nick site (nic) within oriT.

After

nicking, the strand is transferred to the recipient cell
(8,25,28,29,45,49,115,124).

This protein-DNA recognition

has invariably been shown to be unique for a given plasmid
class (i.e., the nicking proteins of 1 plasmid type will
not recognize the oriT of other plasmid types).
Possibly the best characterized DNA processing model
system is that of RP4, a conjugal IncPa broad-host-range
plasmid.

The generation of a single DNA strand destined

to be transferred to a recipient cell begins when complex
nucleoprotein structures called relaxosomes form in a
defined sequence at the oriT of RP4 (67).

First, TraJ

recognizes, and then binds, to the right half of a 19 bp
inverted repeat sequence within the oriT (126).

Then,

TraI recognizes a 6 bp sequence between nic and the TraJbinding site, and joins the TraJ-oriT nucleoprotein
complex (69).

TraH specifically interacts with both TraI

and TraJ, and is proposed to stabilize the relaxosome
(67).

Another protein, TraK, acts to enhance nicking at

oriT (29).

Several molecules of TraK have been found to
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bind to a region of bent DNA adjacent to the nic site,
resulting in a local alteration of DNA superhelicity
{127).

Once the relaxosome is formed, TraI cleaves a

defined strand of
DNA at nic, after
which TraI becomes
covalently
attached to the 5 1
phosphoryl end
{69).

TraI is

also thought to

Schema tar proposed oucleoprotein interactions at the

act in transfer

RP4

oriT

termination in an
undefined way
{70).

This sequence of events leading to single-strand

DNA transfer is not unique to RP4.

Similar

DNA-protein

interactions at oriT have been found in other plasmid
transfer systems as well (8,36,45,49,95).
The sequence of events leading up to the transfer of
DNA has not been fully elucidated in any Bacteroides
plasmid to date.

However, the RP4 relaxosome model may be

applicable to at least some Bacteroides factors.

The

transfer regions of 3 Bacteroides plasmids have been
partially characterized, and all possess some components
analogous to those of the RP4 system.

In the first

example, Hecht et al. have identified 2 genes in the B.
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fragilis clindamycin resistance plasmid pBFTMlO, btgA and
btgB, that are required for mobilization in E.coli when
co-resident with R751, and for self-transfer in B.

fragilis (41).

Both of these genes, and a cis-acting oriT

as well have been cloned.

BtgA, the protein product of

btgA, has been found to specifically bind oriTpBFTMio, and
is thought to play a part in the initiation of transfer
(D.W. Hecht, personal communication).

In the second

example, Murphy and Malamy have characterized the
mobilization region of the B. fragilis conjugative
transposon Tn4399 (59).

They have identified 2 genes

required for mobilization, mocA and mocB, and an oriT
(59).

MocA, and MocB are both necessary for site- and

strand-specific nicking at oriTTn 4399

(

60) .

Finally, Li et

al. have characterized the mobilization region of the

Bacteroides chromosomal insertion element NBU 1 (48).
They have identified an oriT, and a gene, mob, required
for mobilization in Bacteroides when co-resident with a
conjugal Tet Element.

In this case, the protein product

of mob bears no homology to known relaxases, but may
participate in DNA nicking at oriT.

CHAPTER 3
MATERIALS AND METHODS

chemicals
Chemicals were purchased from Sigma Chemicals or J.T.
Baker unless otherwise noted.

Bacterial strains
The bacterial strains and their genotypes are given
in table 1.

B. thetaiotaomicron BT4001 is a spontaneous
rifampicin-resistant mutant of B. thetaiotaomicron type
strain 5482 and was generously provided by Abigail Salyers
of the University of Illinois, Urbana.

B. fragilis TM4000

is also known as B. fragilis type strain 638rfm.

B.

fragilis TM4.23 is a variant of B. fragilis TM4000 that
contains the TM230 chromosomal Tet element.

TM4000 and

TM4.23 were generously provided by Michael Malamy of Tufts
University.

B. fragilis LV22 was isolated at a hospital

in Las Vegas, Nevada, and is part of a collection in the
D.W. Hecht laboratory.
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Table 1.--Bacterial strains
Strain

Relevant
phenotypes a

source

Bacteroides spp,
B. fragilis LV22

This study

B. fragilis TM4000

M. Sebald, Pasteur
Institute, Paris France,
as 638rfm

B. fragilis TM4.23

Tcr, Rifr , B.
fragilis TM4000 +
TMP230 Tet Element

B. thetaiotaomicron
BT4001

Hecht, D.W. & Malamy, M.
(42)
Shoemaker, N. & Salyers,
(106)

A.

B. thetaiotaomicron
BT22.47

This study

Escherichia coli
E.coli HB101

Smr, recA13

Sambrook et al.

E.coli DHScx

Nalr, recAl

Gibco BRL, Gaithersburg,
MD USA

E. coli DW1030

Spr, recA13

Robillard et al.

(90)

(81)

Note:aNalr, Rifr, Spr, Smr, and Tcr indicate resistance to nalidixic
acid, rifampicin, spectinomycin, streptomycin and tetracycline,
respectively.

Bacterial Media
Bacteroides were grown in BHIS medium,

(3.7% (w/v)

BHI medium (BBL), 0.5% (w/v) yeast extract (Difeo),
0.0005% (w/v) hemin) at 37° C under anaerobic conditions
(5% CO 2 , 10% H2 , 85% N3 ) .

E.coli was grown in modified

Luria (ML) medium (1.0% (w/v) tryptone (Difeo), 0.5% (w/v)
yeast extract (Difeo), 0.5% (w/v) NaCl, 0.2% (w/v) K2HP0 4 )
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at 37°

c.

Agar (Difeo) was added to BHIS and ML broths at

1.5% (w/v) for plating.

Antibiotics
Antibiotic concentrations used for selection of
strains and plasmids were: ampicillin (Marsam
Pharmaceuticals), 200 µg/ml; chloramphenicol, 40 µg/ml;
clindamycin (Upjohn), 12 µg/ml; gentamicin (Elkins-Sinn),
40 µg/ml; kanamycin, 50 µg/ml (25 µg/ml when used in
combination with other antibiotics); streptomycin, 50
µg/ml; spectinomycin, 50 µg/ml; and tetracycline, 10
/

µg/ml (E. coli) or 5 µg/ml (Bacteroides).

E. coli

strains containing R751 were grown on Meuller-Hinton
medium supplemented with 10 µg/ml trimethoprim.
Ampicillin, clindamycin, kanamycin, streptomycin, and
spectinomycin were dissolved in water, filter-sterilized,
and stored at -20°

c.

Gentamicin was supplied in a

sterile, aqueous solution and stored at room temperature.
Tetracycline was dissolved in 95% (v/v) EtOH {Aldrich) and
stored at -20°

c.

Trimethoprim was dissolved in 70% (v/v)

EtOH {Aldrich) and chloramphenicol was dissolved in 95%
(v/v) EtOH (Aldrich).

Both were stored at 4°

c.

Aqueous

antibiotic solutions were used within 1 year of
preparation; ethanolic solutions were used within 2 weeks.
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Whole-cell DNA Preparation
Whole-cell DNA was prepared essentially as described
by Saito and Muira (84).

A 10 ml volume of saturated

Bacteroides or E.coli culture was transferred to a 40 ml
Oakridge tube, and collected by centrifugation (7.8
kRCFave, 10 min, at 4° C).

The cells were washed once in

50 ml of saline-EDTA (0.15 M NaCl, 0.1 M EDTA pH 8.0),
collected by centrifugation, and suspended in 5 ml of
saline-EDTA supplemented with 4 mg of lysozyme.

The cells

were incubated 20 min at 37° C and then quick-frozen in an
EtOH/dry ice bath.

5 ml of Tris-sos buffer (0.1 M Tris pH

9.0, 1% sodium dodecyl sulfate, 0.1 M NaCl) was added, and
the cells thawed with gentle mixing in a 50°

c

water bath.

The lysate was then diluted with 5 ml of saline-EDTA.

5

ml of phenol (United States Biochemical) :chloroform:
isoamyl alcohol (25:24:1) was added to the lysate, the
mixture briefly shaken and placed on ice for 15 min.

The

lysate was then centrifuged at 11 kRCFave for 30 min at 20°
C.

The aqueous phase was -transferred to a fresh Oakridge

tube.

The phenol extraction step was repeated once if

Bacteroides cells were used.

1 volume of 2-propanol was

added and the mixture incubated 30 min at R.T.

The

precipitated nucleic acids were then collected by
centrifugation (15.6 kRCFave, 15 min, 20° C), the supernate
removed, and the nucleic acids dried in a vacuum
desiccator for 30 min at room temperature (R.T.).

They
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were then dissolved in 1 ml TE (30 mM Tris pH 8.0, 5 mM
EDTA) supplemented with 40 µg/ml of DNAse-free RNAse A,
and incubated 30 min at 37° c to digest RNA.

small-scale Plasmid DNA Preparation
Plasmid DNA for endonuclease restriction analysis as
well as some DNA sequencing was prepared by miniprep
alkaline lysis as described by Sambrook et al.

(88).

In a

microcentrifuge tube, 1.5 ml of saturated E.coli culture
or 3.0 ml of saturated Bacteroides culture was briefly
spun in a microcentrifuge.

The supernate was then

removed, and the cells suspended in 100 µl of Solution 1
(50 mM glucose, 10 mM EDTA, 25 mM Tris pH 8.0).

To lyse

the cells, 150 µl of fresh Solution 2 (0.2 M NaOH, 1%
(w/v) sodium dodecyl sulfate) was added, mixed gently, and
placed on ice for 5 min.

150 µl of Solution 3 (5 M

potassium acetate, pH 4.8) was added, mixed gently, and
the mixture again iced for 5 min.
centrifuged for 15 min at

4°

c.

The mixture was then
The supernate,

containing plasmid DNA, cellular RNA, and protein, was
transferred to a new microcentrifuge tube and extracted
once with phenol (United States Biochemical) :chloroform
(1:1).

If a Bacteroides strain was lysed, the phenol

extraction was repeated once.

The aqueous phase was then

transferred to a new microcentrifuge tube, and 2 volumes
of 95% (v/v) EtOH (Aldrich) added.

The solution was kept
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at -70° C for 5 min, and the nucleic acids collected by
centrifugation in a microcentrifuge.

The supernate was

drained, the nucleic acid pellet washed with ice-cold 70%
(v/v) EtOH {Aldrich), and the pellet dried for 5 min at
37°

c.

The nucleic acids were then dissolved in TE (30 mM

Tris pH 8.0, 5 mM EDTA) supplemented with 40 µg/ml of
DNAse-free RNAse A, and the solution incubated for 30 min
at 37° c to digest RNA species.
When preparing mini-prep plasmid DNA for sequencing,
the following modifications were made: (a) 5 ml of
bacterial culture was used instead of 1.5 ml; (b) cleared
lysates were extracted twice with phenol:chloroform,
followed by an extraction with chloroform.

Large-scale Plasmid DNA Preparation
Large-scale plasmid DNA was prepared by 2 methods:
(a) Qiagen affinity column purification (Qiagen Corp), as
instructed by the manufacturer; (b) large-scale alkaline
lysis with CsCl equilibrium gradient purification
essentially as described by Sambrook et al. (90).

The

latter procedure was performed as follows: a 100 ml
culture of E.coli, containing the plasmid to be purified,
was grown to saturation with antibiotic added for plasmid
maintenance.

The cells were collected by centrifugation

(10.2 kRCFave, 10 min, 4° C), suspended in 10 ml of
Solution 1 {50 mM glucose, 25 mM Tris pH

a.o, 5 mg/ml
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lysozyme, 10 mM EDTA), transferred to a 40 ml Oakridge
tube, and incubated for 5 min at R.T.

To lyse the cells,

20 ml of fresh Solution 2 (0.2 M NaOH, 1% (w/v) sodium
dodecyl sulfate) was added and mixed gently, and the
solution incubated at R.T. for 10 min.

15 ml of Solution

3 (5 M potassium acetate, pH 4.8) was added, mixed, and
the solution placed on ice for 10 min.

The mixture was

then centrifuged for 30 min at 26.7 kRCFa=, 4° c.

The

supernate was transferred into two 40 ml Oakridge tubes,
and 0.6 volumes of 2-propanol added to each tube to
precipitate nucleic acids.

The tubes were incubated for

15 min at R.T. and centrifuged for 30 min at 26.7 kRCFave,
20°

c.

The supernates were then drained, and the nucleic

acids dissolved in 7.4 ml TE {30 mM Tris pH 8.0, 5 mM
EDTA).

To isolate and purify the plasmid DNA, CsCl

equilibrium gradient separation was performed.

To 7.4 ml

of nucleic acid solution, 1 g of CsCl and 0.8 ml of 10
mg/ml ethidium bromide were added, mixed, and centrifuged
for 16 hat 183.2 kRCFmax, 20° C.

The plasmid bands were

then harvested from the CsCl gradients by side puncture,
pooled, and the ethidium bromide extracted with 2-propanol
saturated with l0X SSC (1.5 M NaCl, 0.15 M trisodium
citrate pH 7.0). The DNA was then precipitated in a 40 ml
Oakridge tube by adding an equal volume of TE and 2
volumes of 95% (v/v) EtOH (Aldrich) and overnight storage
at -20°

c.

The precipitated DNA was then collected by
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centrifugation {15.6 kRCFave, 30 min, at 4° C), the
supernate removed, the pellet dried in a vacuum
desiccator, and then suspended in 2 ml TE.

Restriction Endonuclease Digestion
Restriction endonuclease digestions were performed as
described in Sambrook et al. {89), using enzymes and
reaction buffers supplied by New England Biolabs, Promega,
or Stratagene.

s1 Nuclease Digestion
In some instances, Sl nuclease {Promega) was used to
generate blunt-ended DNA prior to ligation.

Digestions

were typically done in a 50 µl volume in Sl nuclease
buffer (0.25 M NaCl, 15 mM acetic acid, 15 mM potassium
acetate pH 4.5, 1 mM ZnSO 4 , 5% (v/v) glycerol) using 25
units of enzyme.

The mixture was incubated for 1 hat

R.T. and the DNA purified by agarose gel electrophoresis.

Agarose Gel Electrophoresis
Gel electrophoresis was performed using agarose
concentrations of 0.6%-2.0% according to DNA fragment
size, and lX SB3 running buffer (37.5 mM Tris, 8.0 mM
sodium acetate, 0.8 mM EDTA, pH 7.9).

Gel slabs were then

stained with 0.5 µg/ml of ethidium bromide and the DNA
visualized by short-wave UV light.
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Extraction of DNA from Agarose Gels
DNA fragments that were to be used in molecular
cloning procedures were generally purified by agarose gel
electrophoresis and then extracted from the agarose with
the Gene-Clean II System (Bio 101) if greater than 500 bp
in size, or with the Wizard PCR Prep Purification System
(Promega) if less than 500 bp.

Both systems were used as

instructed by their manufacturers.

DNA Ligation
Cohesive-end ligation of DNA fragments was performed
as described by Sambrook et al. (91), using 1.5 U of T4
DNA ligase and buffer supplied by New England Biolabs or
Promega, for 4 hr or overnight at 16°

c.

Blunt-end ligations were performed as described by
Sambrook et al. (91), using T4 DNA ligase, supplied by New
England Biolabs or Promega, and blunt-end ligation buffer
{33 mM Tris pH 7.6, 3 mM MgC1 2 , 5% (w/v) PEGS000, 0.1 mM
ATP, and 5 mM DTT), overnight at R.T.

Prior to ligation, the vector DNA was usually dephosphorylated at its 5 1 ends using calf intestinal
alkaline phosphatase as recommended by the supplier (New
England Biolabs).

Ligated DNA was routinely transformed

to competent E. coli DH5a.
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Preparation and Transformation of competent E, coli
E.coli strains were made competent prior to DNA
transformation using two protocols.

The E.coli strains

DH5a and HBl0l were used on a regular basis for the
transformation of DNA.

Consequently, competent cell

preparations of these 2 strains were prepared and stored
frozen, using the following method: from a bacterial
culture grown to saturation, 1 ml of cells were subcultured to 100 ml of pre-warmed Y broth (0.5% (w/v) yeast
extract (Difeo), 2% (w/v) tryptone (Difeo) and 0.5% (w/v)
MgSO 4 , adjusted to pH 7.6 with KOH) and incubated at 37° c
with vigorous shaking, until the density of cells reached
an OD 5 ~

of 0.48.

The cells were then chilled on ice for 5

min, and collected by centrifugation (3.7 kRCFave, 10 min,
4° C).

The supernate was then drained, the cells

suspended in 40 ml of ice-cold TBFl solution (30 mM
potassium acetate, 100 mM KCl, 10 mM CaC1 2 ,

50 mM MnC1 2 ,

and 15% (v/v) glycerol, adjusted to pH 5.8 with acetic
acid) transferred to a 40 ml Oakridge tube, and chilled on
ice for 5 min.

The cells were collected by centrifugation

(7.8 kRCFave, 10 min, 4° C), the supernate removed, and the
cells suspended in 4 ml of TBF2 solution (10 mM MOPS, 75
mM CaC1 2 , 10 mM KCl, and 15% (v/v) glycerol, adjusted to
pH 6.5 with KOH) and chilled on ice for 15 min.
were then frozen at -70°

c.

The cells

To transform, frozen cells

were thawed and placed on ice for 10 min.

25-100 ng of
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DNA was then added to 50 µl of cells, the cells placed on
ice for 2 min, incubated at 42° C for 1.5 min, then placed
on ice again for 2 min.
R.T.

soc

To rescue the cells, 200 µl of

medium {2% (w/v) tryptone {Difeo), 0.5% (w/v)

yeast extract (Difeo), 10 mM NaCl, 2.5 mM MgC1 2 ,

10 mM

MgSO 4 and 20 mM glucose) was added, and the cells
incubated at 37°

c

for 1 h with vigorous shaking.

100 µl

of cells were then plated to selective medium and the
plate incubated overnight.
For strains of E.coli other than DH5a and HBl0l
that were not routinely transformed, competent cell
preparations were made and used immediately following a
modification of the method of Cohen et al.

(20): a

saturated E. coli broth culture was sub-cultured to prewarmed ML broth and incubated at 37° c with vigorous
shaking until the OD 550 reached 0.5.

The cells were then

collected by centrifugation (7.8 kRCFave, 10 min, 4° C),
the supernate drained, the cells suspended in 1 volume
ice-cold 30 mM CaC1 2 solution and placed on ice for 30
min.

The cells were then collected by centrifugation as

above, the supernate drained, and the cells suspended in
0.1 volume of 75 mM CaC1 2 • 200 µl of these cells were then
added to 25-100 ng of DNA and placed on ice for 60 min.
The cells were then incubated at 42° C for 5 min, and
again placed on ice for 30 min.

To rescue the cells, they

were mixed with 5 ml of R.T. ML broth and incubated for
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2 hat 37° C with vigorous shaking.

A 100 µl aliquot of

this cell suspension was then plated to selective medium,
and the plate incubated overnight.

Plasmid constructions (Table 2)
pGAT400.

pGAT400 is an E. coli-Bacteroides shuttle

plasmid whose characteristics have been previously
described by Hecht and Malamy {42).

It is a fusion of the

E.coli plasmid pDG5 (itself a fusion of the ColEl

replicon, the ampicillin resistance gene, bla, and the RK2
origin of transfer, oriTRK2 (37)) and the B. fragilis
conjugative (i.e., transferable by a conjugation-type
mechanism) plasmid pBFTMl0 {113)

(fig. 1).

pGAT400

confers ampicillin resistance in E. coli owing to the bla
gene, and clindamycin resistance in Bacteroides, due to a
clindamycin resistance gene located on the resident
transposon of pBFTMl0, Tn4400 (81).
In pGAT400, both pDG5 and pBFTMl0 have active
transfer properties.

Thus, when co-resident with an

IncPa conjugal (i.e., self-transferable) plasmid such as
RK2 or pRK231, pGAT400 can be mobilized from E.coli to E.
coli (34), or to Bacteroides (35).

This mobilization is

due to the transfer proteins of pRK231 acting in trans
upon oriTRK2 of pDG5.

pBFTMl0 also has a transfer region

that is comprised of a cis-acting origin of transfer,
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Table 2.--Plasmids

Plasmid

Relevant phenotypes and
characteristics a

Source

R751

IncpB, Tra •, Tmpr

Meyer & Shapiro

(56)
F'lac

IncFI, Tra•, lac•

Pasteur
Institute, Paris,
France

pACYC184

Chang and Cohen
(18)

pGEM7Zf(+)

Promega Corp.
Madison, WI

pBR322

Bolivar et al.
(9)

Covarrubias et
al. (21)

pBR328
pBR328ll

Mob-, Ap', deletion derivative of

This study

pBR328
Hecht, D.W. &
Malamy, M. (42)

pGAT400
pGAT400llBglII

(Tra-), (Ccr), Mob-, Apr, deletion
derivative of pGAT400

Hecht, D.W. &
Malamy, M. ( 42)

pGAT400llori

(Tra-), (Cc'), Mob-, Apr, deletion
derivative of pGAT400

M. Malamy, Tufts
University

pJA-lla

btgA (pBFTMlO) cloned into pETllD

P.J. Arnold

pJA-223B

btgB (pBFTMlO) cloned into pKK223

P.J. Arnold

pJA-7ZT

pBFTMlO oriT cloned into
pGEM7Zf (+)

P.J. Arnold

pLV22a

LV22 native plasmid

This study

pTJ47-1

( Tra•), Mob•, Ap',
pLV22a::pGAT400llBglII fusion

This study

pTJ47-3

(Tra•), Mob•, Ap',
pLV22a::pGAT400llBglII fusion

This study

pTJinsla

Apr, pLV22a ligated into the
pGEM7Zf(+) EcoRI site

This study

pTJins3a

Apr, pLV22a ligated into the
pGEM7Zf(+) EcoRI site

This study
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Table 2--continued
Plasmid

Relevant phenotypes and
characteristics 4

Source

pTJSa

Mob•, Tc', pLV22a ligated into the

This study

pACYC184 EcoRI site
pTJ8

Mob•, Ap', pLV22a ligated into the

This study

pBR3286 EcoRI site
pB22a

Mob•, Ap'' pLV22a ligated to the
3.9 kb pBR322 AatII/BamHI fragment

This study

pTJ6

Mob•, Cm', pLV22a ligated to the
3.8kb pACYC184 XbaI/BamHI fragment

This study

pTJ6XB

Mob•,

Cm', deletion derivative of

This study

pTJ6
pTJlO

(Tra•), (Cc'), Ap'' pLV22a Mob region
ligated into the BglII site of
pGAT4006ori

This study

pTJ12

Mob-, Cm', mbpA deletion derivative

This study

pAC7

Mob-,

pAC18

Mob-, Tc',

TnlOOO mutant of pTJSa

This study

pAC38

Mob-, Tc',

TnlOOO mutant of pTJSa

This study

pAC39

Mob-, Tc',

TnlOOO mutant of pTJSa

This study

pAC49

Mob-, Tc',

TnlOOO mutant of pTJSa

This study

pAC67

Mob-, Tc',

TnlOOO mutant of pTJSa

This study

pBR7

Mob-, Ap''

TnlOOO mutant of pLV22a
ligated into EcoRI site of pBR3286

This study

pBR18

Mob-, Ap''

TnlOOO mutant of pLV22a
ligated into EcoRI site of pBR3286

This study

pBR38

Mob-, Ap''

TnlOOO mutant of pLV22a
ligated into EcoRI site of pBR3286

This study

pBR39

Mob-, Ap',

TnlOOO mutant of pLV22a
ligated into EcoRI site of pBR3286

This study

pBR49

Mob-, Ap''

TnlOOO mutant of pLV22a
ligated into EcoRI site of pBR3286

This study

pBR67

Mob-, Ap',

This study

Tc', TnlOOO mutant of pTJSa

TnlOOO mutant of pLV22a
ligated into EcoRI site of pBR3286

This study
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Table 2--continued
Plasmid

Relevant phenotypes and
characteristicsa

Source

pTJ347

Mob•, Cmr, 347 bp pLV22a oriT PCR
fragment ligated to the 4.1 kb
pACYC184 SalI/SphI fragment

This study

pTJ437

Mob•, Cmr, 437 bp pLV22a oriT PCR
fragment ligated to the 4.1 kb
pACYC184 SalI/SphI fragment

This study

Notes: a Apr, Ccr, Cmr, Tcr and Tmpr indicate resistance to ampicillin,
clindamycin, chloramphenicol, tetracycline and trimethoprim,
respectively. XU refers to the ability of a plasmid to transfer by
a conjugation-type mechanism, while lf1Ql2 refers to the mobilization
phenotype of a tra- plasmid when co-resident with R751 (and wild-type
pLV22a, in the cases of pTJ347 and pTJ437). Parenthesis denotes
phenotypes expressed only in Bacteroides, while no parenthesis
indicates phenotypes expressed only in E.coli.

oriTpBFTMJo, and 2 transfer genes, btgA and btgB (41)

(D.W.

Hecht, personal communication). When co-resident with the
IncPB conjugal plasmid R751, pGAT400 can be mobilized from

E. coli to E. coli or to Bacteroides by the in trans
interaction of the R751 transfer apparatus and the pBFTMlO
transfer region (41).

pGAT400 can also transfer from

Bacteroides to Bacteroides, or to E.coli, through the
expression of the pBFTMlO transfer region (41,42).

pGAT400•BglII and pGAT400•ori.

pGAT400•BglII is a

derivative of pGAT400 that has been deleted for the
transfer genes of pBFTMlO, btgA and btgB, through the
elimination of the pBFTMlO BglII fragments (42).
pGAT400•ori is a related plasmid in which the cis-acting
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oriTpBFTMJo, in addition to btgA and btgB, have been deleted
from pGAT400 (D.W. Hecht, personal communication)
1).

(fig.

In contrast to their parental plasmid, pGAT400,

pGAT400•BglII and pGAT400•ori cannot be mobilized when coresident with R751 in E.coli, and are not transferable in
Bacteroides.

Like pGAT400, pGAT400•BglII and pGAT400•ori

can still be mobilized from E.coli when co-resident with
the IncPa plasmid pRK231, due to the oriTRK2 of the pDG5
portion of these plasmids.

The replication and antibiotic

resistance properties of pGAT400•BglII and pGAT400•ori are
also identical to pGAT400.

pGEM7Zf(+), pBR322, pACYC184, and pBR328.
pGEM7Zf(+), pBR322, pACYC184 and pBR328 have been
previously described (fig. 2).

pACYC184 and pBR328 were

chosen for use in the mating experiments because of their
compatible replicons (pl5A in pACYC184 and ColEl in
pBR328), and because neither pACYC184 (data not shown) nor
pBR328 (21) can be mobilized when co-resident with
conjugal IncP plasmids.

pBR328•.

pBR328• was created for use with pACYC184

in the complementation assays by deleting the tetracycline
and chloramphenicol resistance genes of pBR328.

pBR328

was digested with MscI/EcoRV and the resulting 3.8 kb
fragment self-ligated to give pBR328• (fig. 2).

pBR328•
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contains the pBR328 replication region and ampicillin
resistance gene.

pJA-lla, pJA-223B, and pJA-7ZT.

pJA-lla, pJA-223B,

and pJA-7ZT were created by P.J. Arnold in the laboratory
of D.W. Hecht.

pJA-lla is a 6.3 kb plasmid that contains

a 629 bp PCR-generated copy of the pBFTMlO transfer gene,

btgA, ligated to the large NcoI/BamHI fragment of pETllD.
Similarly, pJA-223B is a 5.5 kb plasmid that contains a
993 bp PCR-generated copy of the pBFTMlO transfer gene,

btgB, ligated to the large EcoRI/PstI fragment of pKK223.
Finally, pJA-7ZT contains a 304 bp PCR-generated copy of
the pBFTMlO oriT, cloned into the BamHI site of
pGEM7Zf(+).

pTJinsla and pTJins3a.

pTJinsla and pTJins3a were

created by ligating the 5.3 kb EcoRI fragments of pTJ47-1
and pTJ47-3 respectively, each containing pLV22a and
IS4400 1etu

into the EcoRI site of the pGEM7Zf(+)

polylinker (figs. 3, 4).

pTJ5a and pTJS.

pTJ5a and pTJ8 were created by

ligating the 5.3 kb EcoRI fragment of pTJ47-1 that
contains pLV22a and IS4400 1ett into the unique EcoRI sites
of pACYC184 and pBR328•, respectively (fig. 3).
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pB22a.

pB22a was created by the ligation of the 5.3

kb AatII/BamHI fragment of pTJinsla that contains pLV22a
and IS4400 1 eft (from pTJ47-1) to the 3.9 kb AatII/BamHI
fragment of pBR322 (fig. 3).

~-

pTJ6 was created by ligation of the 5.3 kb

XbaI/BamHI fragment of pTJins3a that contains pLV22a and
IS4400 1 eft (from pTJ47-3) to the 3.8 kb XbaI/BamHI fragment

of pACYC184 (fig. 4).

pTJ6XB.

pTJ6XB was created to delete IS4400 left and

regions of pLV22a not required for mobilization.

pTJ6 was

first digested with XbaI/BstXI, and then with Sl nuclease
to generate blunt ends.

The resulting 5.5 kb fragment

that contains the pLV22a mobilization region was selfligated to give pTJ6XB (fig. 4).

pTJ10.

pTJlO was created by ligating the 3.3 kb

Sau3AI/BamHI fragment of pTJ6, containing the pLV22a

mobilization region, into the unique BglII site of
pGAT400•ori (fig. 5).

pTJ12.

pTJ12 was developed to delete the first 32 bp

of the mbpA coding region and its promoter.

It was

created by digesting pTJins3a with BsaWI, and then cloning
the resulting 1.4 kb fragment into the XmaI site of the
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Fig. 5. Map of pTJl0. Heavy solid line denotes pLV22a DNA; dotted line represents pGAT400 delta ori
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Restriction sites named in full represent sites in the pGEM7Zf(+) multiple cloning site. Other
restriction sites are as follows:~, BglII; BS, BstXI; E, ClaI; §, EcoRI; HC, HincII; SC, Sac!; and
S3, Sau3AI. Arrow denotes pLV22a mobilization region.
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pGEM7Zf(+) polylinker.

This fragment contains the pLV22a

mobilization region excepting the first 32 bp of mbpA and
its promoter.

The fragment was then excised by digestion

with XbaI/BamHI, and ligated to the 3.8 kb XbaI/BamHI
fragment of pACYC184 (fig. 4).

Tn1000 Random Mutagenesis
Random TnlOOO insertion mutations in the pLV22a
portion of pTJ5a were generated using a modification of
the F plasmid mating protocol as previously described
(39).

A broth culture of the donor, E.coli DW1030

(F'lac) (pTJ5a), and one of the recipient, E.coli HBl0l,
were grown to saturation.

Into 10 ml of pre-warmed ML

broth, 1 ml of donor and 2 ml of recipient were added, the
broth incubated at 37° C for 1 h with vigorous shaking,
and then for an additional 2.25 h with gentle shaking.
The cell suspension was then serially diluted in lX MPBS
(8 mM Na 2HPO 4 , 2 mM NaH2 PO 4 , 145 mM NaCl, pH 6.9), and
aliquots of the dilutions plated to ML medium containing
antibiotic to select for transconjugants (those recipient
cells that successfully received the target plasmid),
which now contained mutant target plasmids with random
insertions of TnlOOO.

Each mutant determined to carry an

insertion in the pLV22a fragment had its internal TnlOOO
BglII fragments deleted to prevent further transposition
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of TnlOOO.

These mutants were designated pACinsert

number,~ designating the pACYC184 replicon.

complementation Analyses
In order to perform the complementation analysis of
mutants pAC7, pAC18, pAC38, pAC39, pAC49 and pAC67, a set
of plasmids containing identically placed insertion
mutations was constructed.

BsaWl fragments internal to

TnlOOO were deleted from pAC7, pAC18, pAC38, pAC39, pAC49
and pAC67, leaving 65 bp of TnlOOO DNA at the sites of
insertion.

A 5.4 kb EcoRI fragment from each of these

mutants, containing pLV22a and the 65 bp of TnlOOO, was
then cloned into the unique EcoRI site of pBR328~.

The

resulting plasmids were designated pBR7, pBR18, pBR38,
pBR39, pBR49, and pBR67 respectively, JIB denoting the
pBR328 replicon.

Quantitative Bacteroides to E, coli and Bacteroides to
Bacteroides conjugative Filter Matings
To determine the transfer frequency (F) of
conjugative plasmids and Bacteroides chromosomal Tet
elements, quantitative Bacteroides-E. coli and

Bacteroides-Bacteroides filter matings were performed as
previously described (112).

Broth cultures of the donor,

containing the plasmid or Tet element to be assayed for
transfer, and of the recipient were grown to mid-log phase
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under appropriate conditions.

Cultures of Bacteroides

containing a Tet element were supplemented with 1 µg/ml
of tetracycline 4 h prior to mating.

The tetracycline was

then removed immediately before mating by washing the
cells once with lX MPBS (8 mM Na 2 HP0 4 ,

NaCl, pH 6.9).

2 mM NaH2 P0 4 ,

145 mM

(Tetracycline induction of Tet elements

leads to increased transfer of both the elements
themselves (74) and co-resident conjugative plasmids such
as pBFTMl0 (104,117).)

Donor and recipient cultures were

then mixed (2.5 ml:2.5 ml) in a Nalgene cellulose nitrate
disposable vacuum filtration unit and the cells vacuumed
unto the filter surface.

The filter was then aseptically

transferred to a BHIS plate, and the plate incubated
anaerobically at 37° C for 18 h.

The filter was then

vigorously washed in lX MPBS for 20 sec to suspend the
cells.

To determine the number of transconjugants/ml

(those recipient cells that received the transferred
plasmid or Tet element), the suspension was serially
diluted in lX MPBS, aliquots of the dilutions plated to
antibiotic medium for selection of transconjugants, and
the plates incubated under conditions suitable for growth
of the recipient strain.

The transconjugant colonies were

then counted. The number of donor cells per ml in the
input mid-log phase culture was also determined by serial
dilution and plating.

F

was then calculated as:

transconjugants/ml + input donors/ml.
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ouantitative R751 Mobilization
To determine the frequency of plasmid mobilization
(F=b), a broth culture of the donor, E.coli HBl0l
containing R751 and the plasmid to be assayed for
mobilization, and one of the recipient, E. coli DW1030,
were grown to mid-log phase.

0.15 ml of the donor and

1.35 ml of the recipient were mixed in a 1.5 ml

microcentrifuge tube, and the cells collected by
centrifugation.

The supernate was removed, the cells

suspended in 100 µ1 of lX MPBS (8 mM Na 2 HPO 4 , 2 mM NaH2 PO 4 ,
145 mM NaCl, pH 6.9), transferred to a 25 mm Nalgene GN-6

cellulose acetate filter supported on ML agar, and
incubated for 3 hr at 37°

c.

The filter was then

vigorously washed in lX MPBS for 20 sec to suspend the
cells.

To determine the number of transconjugants/ml

(those recipient cells that received R751 or the mobilized
plasmid), the suspension was serially diluted in lX MPBS.
Aliquots of the dilutions were then plated to an
antibiotic medium for the selection of R751
transconjugants, and also to a second antibiotic medium
for the selection of mobilized plasmid transconjugants.
The plates were incubated overnight at 37° C, and the
transconjugant colonies counted.

F=b

was then calculated

as follows:
transconjugants=b

plasmid/ml

transconjugantsR 75 i/ml.
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E.coli strain construction using IncP Plasmid Mobilization
Plasmids that are mobilized when co-resident with the
IncP conjugal plasmids R751 or pRK231, as well as the IncP
plasmids themselves, were conjugatively shuttled from one
E.coli strain to second E.coli strain as follows: a

saturated broth culture of the donor strain, containing
R751 or pRK231 (and a mobilizable plasmid, when
applicable), was mixed with an equal volume of saturated
recipient broth culture.

An aliquot of the mixture was

plated to ML agar and incubated for 8 hat 37° c.

A

portion of the resulting culture was then plated to ML
medium containing antibiotics to select for
transconjugants (those recipient cells that received R751,
pRK231 or the mobilized plasmid as desired), and the plate
incubated aerobically overnight at 37° c.

Bacteroides strain construction using pRK231 Plasmid

Mobilization
Plasmids containing the pRK231 origin of transfer,
such as pGAT400 and its derivatives, are efficiently
mobilized from E.coli to Bacteroides when co-resident
with pRK231.

pRK231 mobilizations were performed by

mixing a mid-log phase broth culture of donor E.coli,
containing pRK231 and the plasmid to be mobilized, with an
equal volume of mid-log phase Bacteroides recipient
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culture.

An aliquot of the mixture was then transferred

to a BHIS plate and the plate incubated overnight
aerobically at 37°

c.

A portion of the resulting culture

was then plated to BHIS medium containing antibiotics to
select for transconjugants (those recipient cells that
received the mobilized plasmid), and the plate incubated
anaerobically for 48 hat 37°

c.

DNA seguencing
Nucleotide sequences were determined from double
stranded plasmid DNA templates using the Sequenase system
(United States Biochemical) as instructed by the
manufacturer.

This system uses a modification of the

Sanger method of sequencing DNA by enzymatic labelling of
newly synthesized DNA with (a 35 S] dATP and dideoxynucleotide chain termination (92).

Plasmid DNA used

in determining the primary wild type pLV22a sequence was
prepared by Qiagen affinity column (Qiagen) or CsCl
purification; mini-prep DNA was also used when sequencing
mutants.
Sequencing reactions were electrophoresed in 6% Long
Ranger gel (FMC Bioproducts, Inc.) in 1.2x TBE (10.7 mM
Tris base, 10.7 mM boric acid, 0.24 mM EDTA, pH 8.0), with
an 0.6X TBE (5.3 mM Tris base, 5.3 mM boric acid, 0.12 mM
EDTA, pH 8.0) running buffer and running temperature of
47°

c.

An IBI (International Biotechnologies, Inc.) model
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STS-45 sequencer was used.

DNA sequence ladders were

visualized by placing the dried gel on Kodak X-OMAT AR
film, generally for 36-48 h.
By running a set of sequencing reactions for both 1.5
hand 4.0 hon the same gel, and then splicing the
sequence obtained from both, we were able to regularly
generate 300-350 bp of sequence per gel.
To sequence the pLV22a mobilization region,
oligonucleotide primers directed outward from both ends of
TnlOOO were used: 5 1 -TCAATAAGTTATACCAT-3'
GAATTATCTCCTTAACG-3' (delta).

(gamma) and 5 1 -

Other primers, 17-20 bases

in size, were synthesized as needed to fill gaps and
obtain the complementary DNA sequence.
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P-labeled DNA Probes

Supercoiled plasmid DNA, or DNA fragments previously
agarose gel-purified, were labeled with [~ 32 P] dATP using
the stratagene Prime-It II random-prime labeling system as
recommended by the manufacturer.

Unincorporated

nucleotides were separated from labeled probe DNA using a
G-50 Sephadex spin column (Boerhinger-Mannheim).

southern Blot Analysis
DNA-DNA hybridization analysis was carried out using
a modification of the method of Southern (111).

DNA

fragments to be analyzed were first separated by agarose
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gel electrophoresis.

The DNA was then depurinated by

washing the gel slab in 0.25 M HCl for -5 min at R.T. with
gentle agitation, denatured by washing in 0.4 M NaOH and
0.6 M NaCl for 30 min at R.T. with gentle agitation, and

then neutralized by washing in 0.5 M Tris pH 7.5 and 1.5 M
NaCl for 30 min at R.T. with gentle agitation.

The DNA

was then transferred by capillary blotting or vacuum
transfer to a Genescreen Plus (DuPont) nylon membrane with
l0X SSC (1.5 M NaCl and 0.15 M trisodium citrate pH 7.0).

The membrane was then washed in 0.4 M NaOH for 1 min at
R.T. followed by a 1 m wash at R.T. with 0.2 M Tris pH 7.5
and 2X SSC (0.3 M NaCl and 0.03 M trisodium citrate pH
7.0).

The filter was then dried, and placed in a glass

rotator tube (Robbins Scientific), wetted with 2X SSC, and
pre-hybridized with 5 ml of hybridization solution (0.9

M

NaCl, 0.09 M trisodium citrate pH 7.0, 1% (w/v) sodium
dodecyl sulfate, 100 µg/ml denatured salmon sperm DNA,
0.2% (w/v) Ficoll, 0.2% (w/v) polyvinylpyrolidine and 0.2%

(w/v) bovine serum albumin Fraction V) for 1 hat 65°
32

c.

P-labeled DNA probe was then added to a concentration of

-1 X 10 6 dpm/ml, and the filter incubated 4 h to 18 hat
65°

c with slow rotation.

The membrane was then washed

twice with 2X SSC for 5 min at R.T. twice with warm 2X SSC
and 1% (w/v) sodium dodecyl sulfate for 30 min at 65° c,
and twice with 0.lX SSC (0.015 M NaCl and 0.0015 M
trisodium citrate pH 7.0) for 30 min at R.T.

The membrane
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was then placed on Kodak X-OMAT AR film, generally for 1820 h.

Polymerase chain Reaction (PCB) Amplification of the
pLv22a oriT
The ori T of pLV22a was cloned using a Perkin-Elmer
thermocycler and Core Reagent kit as recommended by the
manufacturer.

36 amplification cycles, a 55° C annealing

temperature and a 30 sec elongation time were used.

A 347

bp product was generated using the primer pair: 5'GCAAGAAGTGTCCTTGTCGG-31 and 3 1-CTCTTGGCCCGTGATTAATG-5 1 •

A

437 bp product was generated using the primer pair:
5-'GCAAGAAGTGTCCTTGTCGG-3 1 and 3'-GTCATGCTGGAGCGGTTTCTC51.

The PCR products were first cloned into the PCR

product cloning site of the pGEM-T vector (Promega).

The

products were then cut out with Sall and SphI restriction
endonucleases, and ligated to the 4.1 kb SalI/SphI
pACYC184 fragment.

The final plasmids, containing the 347

bp and the 437 bp PCR products, respectively, were
designated pTJ347 and pTJ437.
by DNA sequencing.

The products were verified

CHAPTER 4
RESULTS

Description of the Transfer Mechanisms of the B, tragilis
strain Lv22
LV22 is a clinically isolated strain of B. fragilis.
An earlier study of LV22 from the laboratory of D.W. Hecht
determined the following: (~) LV22 contains 2 native
plasmids and a Tet Element.

(Tet Elements are a family of

closely related, self-transferable chromosomal elements
that confer tetracycline resistance in Bacteroides
(74,102)).

(~) LV22 is unexpectedly able to restore

transferability to the normally transfer-deficient (Tra-)
plasmid pGAT400•BglII.

LV22 apparently does so by

complementing in trans for btgA and btgB, the pBFTMlO
transfer genes deleted from pGAT400•BglII.

(btgA and btgB

have not been found in LV22 by high-stringency Southern
hybridization analysis.)

We have termed the mechanism

responsible for transfer of pGAT400•BglII the Trans

Factor.

(k) LV22 can also transfer other Tra- plasmids in

cis; the mechanism responsible for this has been termed
the Cis Factor (data not shown).

LV22 therefore appears

to have three distinct mechanisms implicated in
52
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conjugative transfer (i.e., transfer by a conjugation-type
mechanism): a Tet Element, the Trans Factor, and the Cis
Factor.

The original intent of this dissertation project

was to clone and characterize the LV22 Trans Factor.

conjugative Transfer of the Trans Factor from B, fragilis
Lv22 to B, thetaiotaomicron BT4001
Based upon their different phenotypes, we believed
that the LV22 Trans and Cis Factors were not genetically
linked, and could thus be separated to facilitate their
characterization.

Since the Trans Factor restored a

transferable (Tra+) phenotype to pGAT400•BglII, we
hypothesized that it might also be capable of self-transfer, and consequently could be segregated from the Cis
Factor.

To test whether the Trans Factor was indeed

transferable, a filter mating between LV22 and B.

thetaiotaomicron BT4001 was performed.

BT4001 was chosen

since it contains no known transfer factors (101), and can
not transfer pGAT400•BglII (data not shown).

Direct

selection for transfer of the Trans Factor was not
possible, since the Trans Factor is apparently cryptic.
Based upon the possibility of unlinked co-transfer of the
Trans Factor and the Tet Element, we instead used
tetracycline to select for transfer of the LV22 Tet
Element.
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In the mating between B. fragilis LV22 and B.
thetaiotaomicron BT400l, transfer of the Tet Element from

LV22 to BT4001 occurred at a frequency of 7.2 X 10- 6
transconjugants (those BT4001 recipients that received the
Tet Element) per input donor.

From these, fifty

tetracycline resistant transconjugants were chosen for
further characterization, and were designated BT22,1
through BT22,50 (B. thetaiotaomicron .BT4001 X B. fragilis
LV.2..2.) •

Investigation of the Transfer Properties of B,

thetaiotaomicron strains BT22.1-BT22,so
our next objective was to determine whether any of
the B. thetaiotaomicron BT22 transconjugants contained the
LV22 Trans Factor.

In LV22, the Trans Factor has the

ability to transfer the Tra- plasmid pGAT400•BglII.

We

therefore screened BT22.1-BT22.50 for the presence of the
Trans Factor by filter mating BT22.l (pGAT400•BglII) BT22.50 (pGAT400•BglII) with E.coli HBl0l.

37 of the 50

BT22 strains transferred pGAT400•BglII to HBl0l at
frequencies comparable to the transfer of pGAT400•BglII
from LV22 (data not shown).

These data suggested that the

37 BT22 strains contained the LV22 Trans Factor.

However,

when transconjugant plasmid DNA transferred from the 37
BT22 strains was analyzed, pGAT400•BglII was frequently
found to have been altered.

This was in direct contrast
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to LV22, which did not alter pGAT400•BglII upon transfer
(D.W. Hecht, personal communication).

Aval restriction

endonuclease analysis of pGAT400•BglII from 44
transconjugants found that while 76% appeared unaltered,
20% displayed significant deletions of DNA, the majority
of which involved the loss of a 4.4 kb Aval fragment (fig.
6).

(This fragment contains most of the resident

transposon of pGAT400•BglII, Tn4400 (fig. 1).)

In

addition to the examples of unaltered or deleted plasmid
DNA, restriction endonuclease analysis also identified 2
plasmids that had acquired approximately 1.2 kb of new DNA
in the 4.4 kb Aval fragment of pGAT400•BglII (fig. 7).
We concluded from these data that a genetic element
from LV22 was present in the 37 BT22 strains now capable
of transferring pGAT4O0•BglII.

However, the differential

phenotypes of pGAT400•BglII transfer observed in LV22 and
the 37 BT22 strains made it difficult to determine whether
this element was the Trans Factor.

The appearance of 2

transconjugant plasmids containing 1.2 kb insertions of
exogenous DNA was nonetheless considered significant,
since we hypothesized that the insertions might contain
transfer regions that were responsible for the plasmid's

Tra+ phenotype.

We thus decided to analyze the 2 insert-

bearing plasmids further, and named them pTJ47-1 and
pTJ47-3.
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Fig. 6. AvaI restriction digestion patterns of B. thetaiotaomicron
BT22.1-BT22.50 (pGAT400de1taBglII) XE. coli HB101 transconjugant
plasmids.
Gel~: lanes 1-13, AvaI digested transconjugant plasmids;
lane 14, AvaI digested pGAT400de1taBglII; lane 15, undigested
pGAT400de1taBglII; lane 16, 1 kb ladder.
Gel~: lane 1, 1 kb ladder;
lane 2, undigested pGAT400de1taBglII; lane 3, AvaI digested
pGAT400de1taBglII; lanes 4-16, AvaI digested transconjugant plasmids.
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Fig. 7. AvaI restriction digestion patterns of pTJ47-1 and pTJ47-3.
Gel~: lane 1, 1 kb ladder; lane 2, undigested pGAT400de1taBglII;
lane 3, AvaI digested pGAT400de1taBglII; lanes 4-16, AvaI digested
transconjugant plasmids. Gel~: lane 1, 1 kb ladder; lane 2,
undigested pGAT400de1taBglII; lane 3, AvaI digested pGAT400de1taBglII;
lanes 4-12, AvaI digested transconjugant plasmids.
Lane 8 contains
pTJ47-1; lane 9 contains pTJ47-3.
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Initial Analysis of the Exogenous DNA of pTJ47-1 and
pTJ47-3
The first step in the characterization of pTJ47-1 and
pTJ47-3 was to determine the locations of the new DNA
within the parental plasmid, pGAT400•BglII, using
restriction endonuclease mapping.

The exogenous DNA of

pTJ47-1 and pTJ47-3 was initially positioned within a
region of pGAT400•BglII containing a resident transposon,
Tn4400.

Tn4400 consists of a core region, encoding

antibiotic resistance determinants, and identical IS
elements, IS4400 1 eft and IS4400right, which flank the core in
a directly repeated orientation.

The IS elements are

responsible for transposition of the transposon, and both
the external and internal ends of the IS elements are
functional in this regard (81).

Additional restriction

endonuclease analysis found that while IS4400 left and
IS4400right

were intact, the 3. O kb core region of Tn4400

had been deleted (fig. 8).

DNA sequencing of the

junctions between the IS ends and the exogenous DNA
confirmed that the core of Tn4400, up to the ends of
IS4400 1 eft

and IS4400rightt had been replaced with new DNA

(data not shown).

Consequently, pTJ47-1 and pTJ47-3 did

not carry simple 1.2 kb insertions as originally thought,
but instead had simultaneously lost 3.0 kb of Tn4400 core
DNA and acquired 4.2 kb of new DNA in its place.
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Fig. 8. Maps of (A.) pGAT400 delta BglII, (~) pTJ47-1 and (,S_) pTJ47-3.
Restriction enzymes are
as follows:~, Aval; BS, BstXI; BT, BstUI; ~, ClaI; ~, EcoRI; EV, EcoRV; ~, HindIII; HC, HincII;
~, NsiI; S3, Sau3AI; and SC, SacI. Stippled boxes at the left and right ends of Tn4400 are
IS4400left and IS4400right, respectively. Section A: linear map of pGAT400 delta BglII, the
parental plasmid of pTJ47-1 and pTJ47-3.
The dotted box is expanded in Section B. Cc denotes
clindamycin resistance determinant.
Section B: linear maps of pTJ47-1 and pTJ47-3, indicating the
regions of new DNA within pGAT400 delta BglII, and showing the accompanying new restriction sites.
Dotted line denotes 1.8 kb SacI-EcoRV probe fragment.
// denotes truncated DNA.
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Endonuclease restriction mapping of the exogenous DNA
in pTJ47-1 and pTJ47-3 identified similar BstXI, EcoRV,
HincII, NsiI, SacI and Sau3AI restriction endonuclease
sites in the new regions of the plasmids, although the
sites in pTJ47-1 appear to be shifted with respect to the
sites in pTJ47-3 (fig. 8).

These data suggested that the

exogenous DNA of pTJ47-1 and pTJ47-3 was an identical, 4.2
kb plasmid.

Determination of the origin of the Exogenous DNA of
pTJ47-1 and pTJ47-3
our next objective was to learn if the exogenous DNA
of pTJ47-1 and pTJ47-3 was a 4.2 kb plasmid as we
suspected, and to determine the origin of this DNA.
pTJ47-1 and pTJ47-3 were formed when their parental
plasmid, pGAT400•BglII, was transferred from B.

thetaiotaomicron BT22.47 to E.coli HBlOl, and acquired
new DNA in the process.

BT22.47 in turn is a result of a

mating between B. fragilis LV22 and B. thetaiotaomicron
BT4001, and contains DNA from both parents.

Thus, the new

DNA of pTJ47-1 and pTJ47-3 potentially had its origins in
LV22, BT4001, or both strains.

We utilized high-

stringency Southern hybridization analysis to determine
the source and nature of the exogenous DNA.

First, the

5.3 kb restriction endonuclease Aval fragment of pTJ47-1,
containing the exogenous DNA and IS4400 1 eft (fig. 8), was
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labeled with [ 32 P] and used to probe whole-cell LV22 and
BT4001 DNA digested with BamHI/SmaI, EcoRI, EcoRV and

HindIII restriction endonucleases.

The 5.4 kb AvaI

fragment of pTJ47-1 hybridized with LV22 DNA, while no
homology was exhibited with BT4001, indicating that the
exogenous DNA was derived from LV22 alone (fig. 9).
Furthermore, the relatively high intensity of the
autoradiograph bands supported our premise that the
exogenous DNA was one of two plasmids native to LV22.

(A

similar-sized plasmid is also present in BT22.47, but not
BT4001, as seen in EtBr-stained agarose gels (data not
shown).)

A second Southern hybridization was then

performed to determine the relationship between the
exogenous DNA of pTJ47-1 and pTJ47-3, and the plasmids
present in LV22 and BT22.47.

Plasmids from B. fragilis

LV22, B. thetaiotaomicron BT4001 and B. thetaiotaomicron
BT22.47, and plasmids pTJinsla and pTJins3a, were digested
with HincII/EcoRV.

(pTJinsla and pTJins3a contain the

exogenous DNA fragments of pTJ47-1 and pTJ47-3,
respectively (Figs. 3 and 4).)

The cloning vector of

pTJinsla and pTJins3a, pGEM7Zf(+), was digested with PvuI
and included as a negative control.

The resulting digests

were separated by agarose gel electrophoresis, transferred
to nylon membranes, and then probed with a [ 32 P]-labeled
1.8 kb SacI/EcoRV fragment of pTJ47-1.

This fragment is

internal to the exogenous DNA of pTJ47-1, and overlaps the
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4.2kb-..

undig. ···· ►

Fig. 9.
Southern hybridization autoradiograph of B. fragilis LV22
and B. thetaiotaomicron BT4001 total DNA probed with the 5.4 kb AvaI
fragment of pTJ47-1.
Lane loading: 1-2, EcoRI digested LV22 DNA;
i, EcoRI digested BT4001 DNA; 4-5, EcoRV digested LV22 DNA;~,
EcoRV digested BT4001 DNA; 7-8, BamHI/SmaI digested LV22 DNA;~,
BamHI/SmaI digested BT4001 DNA; 10-11, HinDIII digested LV22 DNA;
12, HinDIII digested BT4001 DNA. undig. represents probable
undigested DNA. Autoradiograph was exposed for 2 d.
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internal HincII/EcoRV fragments of the exogenous DNA in
both pTJ47-1 and pTJ47-3 (fig. 8).

The probe hybridized

to 1.2 kb and 3.0 kb HincII/EcoRV plasmid fragments of
LV22 and BT22.47, to the 1.2 kb HincII/EcoRV fragment

internal to the exogenous DNA of pTJ47-1, and to the 3.0
kb HincII/EcoRV fragment internal to the exogenous DNA of
pTJ47-3.

(The probe also hybridized to vector/insert

junction fragments from pTJ47-1 and pTJ47-3.)

No homology

was detected with BT4001 DNA, nor with the cloning vector,
pGEM7Zf(+) (fig. 10).

The results of this study, together

with restriction analysis data, indicate that pTJ47-1,
pTJ47-3, LV22 and BT22.47 all contain a related, and
probably identical, 4.2 kb plasmid that we have designated
pLV22a.
These data indicated that pLV22a had transferred from

B. fragilis LV22 to B. thetaiotaomicron BT4001 during the
original mating that produced B. thetaiotaomicron BT22.47.
We hypothesized that pLV22a might contain an active
transfer region, and was therefore responsible for its own
transfer into BT4001.

Our next set of experiments were

therefore designed to investigate what transfer
properties, if any, were possessed by pLV22a.
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7.0kb
5.2
undig.

3.0

1.2

Southern hybridization autoradiograph of B. fragilis LV22,
B. thetaiotaomicron BT4001, and B. thetaiotaomicron BT22.47
plasmids probed with the 1.8 kb SacI/EcoRV fragment of pTJ47-1.
Lane
loading:!, PvuII digested pGEM7Zf(+); ~, EcoRV/HincII digested
pTJinsla; 1, EcoRV/HincII digested pTJins3a; !, EcoRV/HincII
digested plasmid contents of LV22; ~, EcoRV/HincII digested plasmid
contents of BT4001; ~ EcoRV/HincII digested plasmid contents of
BT22.47.
undig. represents probable undigested plasmid DNA.
Autoradiograph was exposed for 30 rn.
Fig. 10.
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Investigation of the Transfer Properties of pLV22a While
in E, coli
Our next line of inquiry attempted to define what
transfer capabilities were possessed by pLV22a, and to
thus confirm that pLV22a was responsible for the Tra+
phenotype of pTJ47-1 and pTJ47-3.

pLV22a is a B. fragilis

plasmid, and accordingly we predicted that it would be
transferable from that species.

However, pTJ47-1 and

pTJ47-3 could not be tested for transfer from a B.

fragilis host, since they carried no antibiotic resistance
genes expressed in Bacteroides.

(The clindamycin

resistance gene of their parental plasmid, pGAT400•BglII,
had been deleted during the formation of pTJ47-1 and
pTJ47-3.

pTJ47-1 and pTJ47-3 thus could not be detected

by antibiotic selection in B. fragilis.

See Initial

Analysis of the Exogenous DNA of pTJ47-1 and pTJ47-3,
Chapter 4.)

We therefore decided to initially test pLV22a

for transfer in E.coli.

This was not without precedent.

The Bacteroides plasmids pBFTMl0 and pBS-51, and the

Bacteroides transposon Tn4399, cannot transfer from E.
coli unassisted.

However, they can all transfer from E.

coli when co-resident with R751, a conjugal broad-hostrange IncPB plasmid (i.e., they are mobilized when coresident with R751; Mob+)

(59,104,117).

To test whether pTJ47-1 and pTJ47-3 are mobilized
when co-resident with R751, E.coli HBl0l (R751) (pTJ47-1)
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and HBlOl (R751) (pTJ47-3) were filter mated with E.coli
DW1030.

pTJ47-1 and pTJ47-3 were mobilized at frequencies

similar to that of pBFTMlO (in pGAT400), when co-resident
with R751

(table 3).

This was in direct contrast to the

parental plasmid of pTJ47-1 and pTJ47-3, pGAT400•BglII,
which was not mobilized (Mob-).

Thus, the mobilization of

pTJ47-1 and pTJ47-3 is directly attributable to pLV22a.
However, pLV22a, like pBFTMlO, pBS-51, and Tn4399,

requires the co-residence of R751 for mobilization in E.
coli.

Table 3.--R751 mobilization of pLV22a derivatives in E.coli

Plasmids

Presence of pLV22a
in cis
(+/--)

Mean frequency of
mobilizationa
(± SEM)
2.9 (±1.2) X 10~

pGAT400
pGAT400t.BglII

< 1.0

pACYC184

< 1.0

pTJ47-1

+

3. 7 (±1.9) X 10- 3

pTJ47-3

+

3.9 (±0.6) X 10~

pTJSa

+

3.2 (±0.4) X 10~

pTJ6

+

1. 0 (±0. 5) X 10-2

pTJ6XB

+

7.5 (±2.8) X 10~

Notes: Plasmids were mobilized from E.coli HB101 containing
R751 to E.coli DW1030.
a Mobilization frequency is defined as the number of plasmid
transconjugants / number of R751 transconjugants in the same
mating (N=3). 1 X 10-5 defines the limit of detection.
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The Mobilization of pLV22a Independent of pGAT400•BglII
We next wanted to determine whether pLV22a contained
a mobilization region capable of functioning independently
of pGAT400•BglII.

To investigate this, the 5.3 kb EcoRI

restriction endonuclease fragment from pTJ47-1, containing
pLV22a, was ligated into the Mob- cloning vector pACYC184
to give pTJ5a (fig. 3).

Similarly, the 5.3 kb EcoRI

restriction endonuclease fragment from pTJ47-3, containing
pLV22a, was ligated into pACYC184 to give pTJ6 (fig. 3).
pTJ5a and pTJ6 were then tested for mobilization when coresident with R751 by mating E. coli HBlOl (R751) (pTJ5a)
and HBlOl (R751) (pTJ6) with E.coli DW1030.

pTJ5a and

pTJ6 were both mobilized at levels comparable to the
pLV22a::pGAT400•BglII fusion plasmids pTJ47-1 and pTJ47-3
(table 3).

These results indicate that pLV22a provides

the functions required for its mobilization, and can thus
operate independently of pGAT400•BglII in this regard.

comparison of pLv22a to the Transfer Region of pBFTMlo
We wished to learn whether pLV22a was related to
pBFTMlO, the only other Bacteroides transferable plasmid
characterized at the time (41).

We used a study based

upon high-stringency Southern hybridization analysis to
determine whether pLV22a possessed homology to the pBFTMlO
origin of transfer (oriT), or its transfer genes, btgA and
btgB.

pTJinsla and pTJins3a, containing pLV22a from
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pTJ47-1 and pTJ47-3 respectively, were digested with EcoRI
restriction endonuclease, the resulting fragments were
separated by agarose gel electrophoresis and then
transferred to 3 nylon membranes.

These membranes were

then probed with [ 32 PJ-labeled plasmids containing either
the pBFTMl0 oriT (pJA-7ZT), btgA (pJA-lla), or btgB
(pJA-223B).

No hybridization was detected between any of

these probes and the 5.3 kb EcoRI restriction fragments of
pTJinsla and pTJinsJa, containing pLV22a (data not shown).
We therefore concluded from these data that no significant
homology exists between the mobilization region of pLV22a
and the transfer region of pBFTMl0.
We had now isolated a novel B. fragilis transfer
factor, pLV22a, for which we had direct evidence of
mobilization in E.coli, and transfer in B. fragilis.
Because of this, we decided to shift the focus of our
study from the LV22 Trans Factor to pLV22a.

Localization of the pLV22a Mobilization Region by Tn1000
Random Insertion Mutagenesis
Our next objective was to identify the region of
pLV22a required for mobilization in E.coli when coresident with R751.

We used the transposon TnlOOO to

mutagenize pLV22a, thereby inactivating the region(s) of
pLV22a necessary for mobilization.

The target plasmid,

pTJ5a, was mutagenized by mating E.coli DWl0J0
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(F'lac) (pTJ5a) with E.coli HBl0l.

Of 50 TnlOOO insertion

mutations generated, 37 were restriction endonuclease
mapped to the pLV22a portion of pTJ5a (fig. 11).

Each of

the 37 mutants was then further tested for mobilization
from E.coli HBl0l (R751).

Ten mutants, pAC67, pAC38,

pAC39, pAC7, pAC49, pAC18, pAC20, pACll, pAC47, and pAC42
were found to be Mob- (data not shown).

Restriction

endonuclease mapping revealed that the mutations of the 10
Mob- plasmids were located in a contiguous 1.5 kb region

of pLV22a (fig. 11).

The other 27 mutants remained Mob+,

and mapped to the remaining 2.7 kb of pLV22a.
To verify that the 1.5 kb region of pLV22a identified
by TnlOOO mutagenesis was sufficient for mobilization, the
region was sub-cloned, (along with 0.2 kb of upstream DNA)
into the Mob- cloning vector pACYC184, giving pTJ6XB.
pTJ6XB was then tested for mobilization when co-resident
with R751 by filter mating E.coli HBl0l (R751) (pTJ6XB)

with DW1030.

As predicted, mobilization of pTJ6XB was

comparable to the parental plasmid pTJ6 (table 3).

These

results indicate that the 1.5 kb region of pLV22a
identified by TnlOOO mutagenesis is sufficient for
mobilization from E.coli, when co-resident with R751.

Transfer of pLv22a from B, tragilis
We hypothesized that pLV22a, a B. fragilis plasmid,
would be transferable in B. fragilis.

To test this
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Fig. 11. Map of TnlOOO insertions in pLV22a, as found in pTJSa. Heavy solid line denotes pLV22a DNA.
// denotes truncation of vector DNA.
Stippled box represents IS4400left.
Restriction sites are as
follows:~, Aval;~, EcoRI; EV, EcoRV; and SC, SacI. Open symbols indicate mobilization-deficient
TnlOOO insertions; closed symbols represent mobilization-proficient insertions. Numbers above circles
indicate mutant numbers (see text).
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hypothesis, a 3.3 kb Sau3AI/BamHI fragment containing the
pLV22a mobilization region was cloned into the unique

BglII site of pGAT400•ori, giving pTJlO (fig. 5).
{pGAT400•ori is a derivative of the E. coli-Bacteroides
shuttle plasmid pGAT400, in which the pBFTMlO transfer
region has been deleted.
Chapter 3.)

See Plasmid Constructions,

Transfer of pTJlO in B. fragilis would be

attributable to the presence of pLV22a in cis, since
pGAT400•ori is transfer-deficient.

pTJlO was tested for

transfer in a mating between B. fragilis TM4000 (pTJlO)
and E. coli HBlOl.

TM4000 was selected as the donor

because it is a well-characterized laboratory reference
strain that is devoid of any detectable transfer factors.
pTJlO was determined to be transferable from TM4000 to E.

coli HBlOl at 7.1 X 10- 9 transconjugants/input donor, a
frequency comparable to that of pBFTMlO in pGAT400 (table
4). These data indicate that the pLV22a mobilization
region functions at a low but measurable frequency in B.

fragilis as well as in E.coli.
It has been previously shown that Bacteroides strains
that contain Tet Elements are able to increase the
transfer of co-resident plasmids such as pBFTMlO and
pBS-51 (117).

Tet Elements are Bacteroides-specific,

chromosomal elements that carry tetracycline, and
sometimes clindamycin, resistance genes, and are capable
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Table 4.--pLV22a transfer from B. fragilis
Mean frequency of transfera

(± SEM)
Plasmids
pGAT400
pGAT400t.ori
pTJl0

From B. fragilis
TM4000

From B. fragilis TM4.23
8.3 (±4. 9) X 10- 5

4.5 (±0.5) X 10- 9

<1.0

X

10- 9

<1.0

X

10- 9

5
1.5 (±1.1) X 10-

7.1 (±3.0) X 10- 9

Notes: Plasmids were transferred from B. fragilis to E. coli HBl0l.
a Transfer frequency is defined as the number of
transconjugants/input donor in the same mating (N=3).
the limit of detection.

of conjugation-type transfer (4,102).

lXl0- 9 defines

The mechanism by

which plasmids use the Tet Element transfer system to
increase the efficiency of their own transfer is not
understood, but is at least superficially similar to the
mobilization of pBFTMlO and pB8-51 by R751 in E. coli.
(See Horizontal Gene Transfer Factors, Chapter 2.)
To determine whether pLV22a transfer would be
enhanced by a co-resident Tet Element, TM4.23 (pTJlO) was
mated with E. coli HBlOl.

(TM4.23 is a Tet Element+

isogeneic derivative of TM4000.)

TM4.23 (pTJlO) was pre-

treated with lµg/ml of tetracycline 2 h prior to mating,
since tetracycline increases the transfer of both Tet
Elements and co-resident plasmids (104,117).

pTJlO was

found to transfer to HBlOl at a frequency of 1.5 X 10-s
transconjugants/input donor, which represents a 3.5 order
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of magnitude increase over its transfer frequency from the
Tet Element- isogeneic strain TM4000 (table 4).

These

results demonstrate that pLV22a transfer in B. fragilis,
like pBFTMl0 in pGAT400, is substantially enhanced by the
co-residence of a Tet Element (table 4).

DNA Nucleotide sequence of the pLV22a Mobilization Region
Our next course of experiments were designed to
identify the pLV22a genes required for mobilization in E.
We began by sequencing the pLV22a mobilization

coli.

region enzymatically by the method of Sanger.

The DNA

sequences of both top and bottom strands were determined
using the following strategy:

(a} a set of pTJ5a mutants

containing TnlOOO transposon insertions located throughout
the mobilization region was selected.

(b) Outward-facing

DNA oligonucleotide primers homologous to the ends of
TnlOOO were used to generate sequence data from each

mutant.

(~) Additional oligonucleotide primers were used

to fill gaps in the DNA sequence that occurred due to
distantly spaced insertion mutations (fig. 12).
Figure
12
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601

TGCCTACGTTTCGAGGTCAGCCCCTCGATAGAGGAAAGCGCCACCTTTAC
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651

GGATGCGGACTGGGCGGAACTTGGTAACGACTTCATGCAGCGCATGGGGT
D A D W A E L G N D F M Q R M G

701

TGGCGAACCACCAGTACATCATCATCCGGCACAGCGGTACGGAGAGCAAG
L A N H Q Y I I I R H S G T E S K

751

AAAGAGCAAGCCCACCTGCACATACTGGCAAACCGGGTTTCCCTTTCCGG
K E Q A H L H I L A N R V S L S G

801

GGAACTGTACCGGGACAACTGGATAGGGAAAAAGGCAACGGAAGCCGCCA
E L Y R D N W I G K K A T E A A

851

ATGCCATAGCCAAGGAACGGAACTTTGTACAGTCGCAGGACATTGGCAAA
N A I A K E R N F V Q S Q D I G K

901

GTCAACAAAGCGGAAATCAAGGAAGCCATGGACGGCGTATTGAAGAAGAT
V N K A E I K E A M D G V L K K M

951

GCAGGGCTTTGACTTTACCAAATTCAAGGAAGAACTTGGTAAGAGAGGTT
Q
G F D F T K F K E E L G K R G

1001

TTAAAGTCCGGGAAGCCAGGGCAAGCACCGGGAAACTTAACGGCTACTAT
F K V R E A R A S T G K L N G Y Y
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1051

GTCACAGCCCGAAGCGGTACGGAGTATAAGGCAAGCGAGATAGGGAAAGG
V T A R S G T E Y K A S E I G K G

1101

CTACACTCTCGCCCATATCGAGCGGACACAAAGCAAACTGAAGTGCAACT
Y T L A H I E R T Q S K L K C N

1151

CAATGAACATATCTCATGGAAACAAACTCACACCCGGAAGCGGCAGCTTC
S M N I S H G N K L T P G S G S F
mbpC
M E T N S H P E A A A S

1201

CAACGTTAAGCAGGGACAGTACAGCCCCCGGAAAAGAAAAGATACAACGC
G

N

R

V

*

K

Q

G

Q

Y

S

P

R

K

R

K

D

T

T

49T

1251

CAAGGGTAAACCCGCAGCTTGCGGTAGAACTGGTGTATCAAGAACTAAAG
P R V N P Q L A V E L V Y Q E L K

1301

CGTGTTGAAGTCTATACGAAGCGCATAGAGGACGCAACAGCCCGAAAGGT
R V E V Y T K R I E D A T A R K V

1351

ACAAATAGACGGGAAAAGCCTTGAAAGTGCCGAAAATCGCCTAAAAAACG
Q
I D G K S L E S A E N R L K N

1401

TGTTGGCGGACTTTGAACGGCAGGGGTACAGAATGAAAAACGGCGGTTAT
V L A D F E R Q G Y R M K N G G Y

1451

GTGGACAAACGAATTTCGTTCTACTCAATCCTTTGTGCTGTTATCTCCCT
V D K R I S F Y S I L C A V I S L

1501

ATTGTTCGCTTGTTTCATGTGCTATCTTTGGACGGATGCAGCCAAAGACC
L F A C F M C Y L W T D A A K D

1551

llT
T42/47
GGGACAACTACAAGCAGTATTATGAATACTACCAAGAGCAGGCAAGGGAA
R D N Y K Q Y Y E Y Y Q E Q A R E

1601

CAAAAGGGGAATAAATAAACATCTAACTTTACGAATTATGGGAACAACGG
Q K G N K *

1651

AACACGAAGAACCCCGGTTCTTCTTCATACTGAACAAGGGTGCGAAGTCC

1701

GGCGGCGAAATCACCCATGCCGTCCTAAACGGTAGTATCG

20T

<I>

T18

28T

1740

Fig. 12. DNA nucleotide (top line) and deduced protein (bottom line)
sequences of the pLV22a mobilization region.
T denotes TnlOOO
insertion sites, given by number (see text).
Inverted repeat
sequences l.Rl. and lB2. are indicated by horizontal arrows above DNA
sequence. Q denotes the insertion site of pGAT4006BglII into pLV22a,
as found in pTJ47-1 (IS4400 1ett ends to the left of nt 101 in pTJ47-1).
~ denotes the insertion site of pGAT4006BglII into pLV22a, as found
in pTJ47-3 (IS4400r 1 ght begins to the right of nt 1608 in pTJ47-3).
Primers used to generate the PCR products of pTJ347 and pTJ437 start
at: ill top strand, pTJ347 and pTJ437; ~ bottom strand, pTJ347; ~
bottom strand, pTJ437. ~ denotes translational stop codons.
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computer Analysis of the pLv22a Mobilization Region DNA
sequence
The primary DNA structure of the pLV22a mobilization
region was analyzed for the presence of open reading
frames (.QR.Es.) with the DNASIS program (version 3.00 for
IBM compatible personal computers, Hitachi Software
Engineering co.).

Based on methionine start sites, 5 open

reading frames {ORFs) of greater than 10 kDa were
identified (fig. 13).
in the top strand.

orf 1, orf 2 and orf 3 are located

orf 1 codes for a theoretical protein

product of 99 amino acids (aa) (11.7 kDa); orf 2 codes for
a theoretical 264 aa protein {29.4 kDa); and orf 3 codes
for a theoretical 150 aa protein (17.6 kDa).

orf 1 and

orf 3 are both in the first reading frame of the top
strand, while orf 2 is in the third reading frame.

orf 1

and orf 2 overlap by 4 bp, while orf 2 and orf 3 overlap
by 44 bp.

The bottom strand of the pLV22a mobilization

region contains 2 ORFs, orf 4 and orf 5.

orf 4 codes for

a theoretical protein product of 170 aa {18.9 kDa), while
orf 5 codes for a theoretical protein product of 119 aa
(13.4 kDa).

orf 4 is in the second reading frame of the

bottom strand, while orf 5 is in third reading frame.
4 and orf 5 overlap by 326 bp.

orf

Numerous ORFs less than 10

kDa in size were also identified (data not shown).
All 10 of the Mob- TnlOOO insertion mutants of pLV22a
disrupt one or more of the 5 mobilization region ORFs

1

3
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II

4
nt 101

nt 1600

◄
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◄
0.1 kb
Fig. 13. Major open reading frames of the pLV22a mobilization region. Solid horizontal line
represents pLV22a mobilization region, as found in pTJ47-1.
Stippled box represents the right end of
IS4400left.
f_j_ denotes truncated DNA. Open symbols indicate mobilization-deficient TnlOOO
insertions, while the closed symbol denotes a mobilization-proficient insertion; numbers correspond
to mutant number.
Nucleotide numbering corresponds to that of pLV22a sequence as found in Figure 12.
Horizontal arrows numbered 1-5 denote open reading frames of the same number.

-.J
-.J
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identified by DNA sequence analysis (fig. 13).

Mob- mutants, 6 were selected for further study.

Of these
The

mutation of pAC67 disrupts orf 1, the mutations of pAC38,
pAC39 and pAC7 disrupt orf 2, and the mutations of pAC49
and pAC18 disrupt orf 3.

The Mob- phenotypes of these

mutants indicate that orf 1, orf 2, and orf 3 are required
for mobilization in E.coli when co-resident with R751.
The mutation of pAC7 also disrupts orf 4 and orf 5 of the
bottom strand.

Thus, orf 4 and/or orf 5 may also be

required for mobilization.
pTJ47-1 and pTJ47-3 were formed when the parental
plasmid, pGAT400•BglII, became inserted into 2 different
sites of pLV22a (See

Initial Analysis of the Exogenous DNA

of pTJ47-1 and pTJ47-3,

this chapter.)

Sequence analysis

discovered that orf 3 in pTJ47-3 was interrupted 7
nucleotides upstream of the translational stop codon by
the insertion of pGAT400•BglII (fig. 12).

In pTJ47-1, orf

3 is intact due to the alternate site of insertion into
pLV22a.

Mutations in ort 1, ort 2, and ort 3 can be complemented

in trans
Based upon TnlOOO mutagenesis data, we concluded that

orf 1, orf 2, and orf 3 are all required for mobilization
in E.coli.

We next used complementation analysis to

demonstrate that orf 1, orf 2, and orf 3 produce trans-
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acting products.

Complementation analysis is an in vivo

procedure that is performed by placing a mutant sequence
and a wild type sequence, each on a different and
compatible plasmid, together in a test cell line or
strain; the strain is then analyzed for a restoration of
the function that had been lost in the mutant.

A

restoration of function indicates that the wild type
sequence provided a trans-acting product (e.g., a protein)
that complemented the product no longer produced in the
mutant.

A refinement of this procedure places 2 different

mutant sequences together in trans, after which gain of
function is measured.

In this case, a restoration of

function to the mutants implies that their mutations are
in different and independently expressed genes, or are in
genes located within different operons.
pLV22a Mob- TnlOOO mutants were first tested for the
restoration of mobility when co-resident with wild-type
pLV22a (and R751) in trans.

E.coli HBlOl (R751) strains,

containing pB22a (i.e., wild-type pLV22a) and either pAC67
(i.e., a mutant of orf 1); pAC38, pAC39, pAC7 (i.e.,
mutants of orf 2); pAC49 or pAC18 (i.e., mutants of orf 3)
were mated with E.coli DW1030 (fig. 13).

pAC67, pAC38,

pAC39, pAC7, pAC49 and pAC18 were all efficiently
mobilized when wild-type pLV22a was provided in trans
(table 5).
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Table s--R751 mobilization of TnlOOO insertion mutants in E.coli
Presence of
pLV22a in trans
(+/--)

Plasmids

Mean Frequency of
Mobilizationa
(±SEM)

Wild-type
pTJSa

NA

pACYC184

+

Mutants of

< 1.0

+

pAC49

1.0 (± 0.8)

X 10~

< 1.0

pAC18

+

pAC18

Mutants of

6. 6 (± 2. 9)

X 10- 3

111QQB

pAC38

< 1.0

pAC38

+

3.8 (± 1.4)

X 10~

< 1.0

pAC39
pAC39

+

9. 0 (± 6. 5)

X

10- 3

X

10~

< 1.0

pAC7
pAC7

+

6.2 (± 3.0)

mb.pA

< 1.0

pAC67
pAC67

< 1.0

rob.pc

pAC49

Mutant of

3.2 (±0.4)

+

2.7 (± 1.1)

X 10~

Notes: Wild type pLV22a was provided in trans, where indicated, as
part of the plasmid pB22a. Plasmids were mobilized from E.coli
HB101 containing R751 (and pB22a, as noted) to E. coli DW1030. NA=
not applicable.
a Mobilization frequency is defined as the number of plasmid
transconjugants / number of R751 transconjugants in the same mating
(N=3). lxl0- 5 defines the limit of detection.
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To ensure that the mutant plasmids had not been
mobilized by a cis-acting mechanism (e.g., cointegrate
fusion with the Tra+ plasmid R751 or the Mob+ wild-type
plasmid pB22a), 5 samples of transconjugant plasmid DNA
from each mating were analyzed by BamHI restriction
endonuclease digestion.

The mobilized mutant plasmids

were found to be unaltered in all cases, supporting the
premise that they had been mobilized in trans (data not
shown).

These results demonstrated that orf 1, orf 2, and

orf 3 of the pLV22a mobilization region produce transacting products which are required for mobilization in E.
coli, when co-resident with R751.

Consequently, we

tentatively designated orf 1, orf 2, and orf 3 as mbpA,
mbpB and mbpC, respectively, for mobilization of a
Bacteroides ~lasmid.
We next used complementation analysis to confirm that
mbpA, mbpB and mbpC produce trans-acting products required
for pLV22a mobilization, and to determine the genetic
organization of mbpA, mbpB and mbpC.

This experiment used

a series of pLV22a Mob- Tn1000 insertion mutants cloned
into both pBR328• (those plasmids with a BR prefix) and
pACYC184 (those plasmids using an~ prefix): mutation 67
(pBR67 and pAC67) in mbpA; mutation 38 (pBR38 and pAC38),
mutation 39 (pBR39 and pAC39) and mutation 7 (pBR7 and
pAC7) in mbpB; mutation 49 (pBR49 and pAC49) and mutation
18 (pBR18 and pAC18) in mbpC (fig. 13).

E.coli HBlOl
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(R751) complementation strains containing both a pBR
mutant plasmid and a pAC mutant plasmid were then mated
with E.coli DW1030, and the mobilization frequencies of
the pAC plasmid calculated.

The mobilization of a pAC

plasmid would indicate that its mutation and the mutation
of its co-resident pBR plasmid were in different,
independently expressed genes.

Conversely, the lack of

pAC plasmid mobilization would indicate that its mutation
and that of its co-resident pBR mutant were located in the
same gene, or in 2 genes forming an operon.

complementation analysis of mutations in mbpc.

The

coding region of the putative mobilization gene mbpC
extends from nucleotide (nt) 1166 to nt 1618 in the pLV22a
mobilization region sequence (fig. 12), and codes for a
theoretical 17.6 kDa protein.

Two Tn1000 insertion

mutations were generated in mbpC: the mutation of pAC49
occurs at nt 1279, while that of pAC18 occurs at nt 1498
(fig. 12).

Both pAC49 and pAC18 are Mob-, but can be

mobilized from E.coli when wild-type pLV22a is present in

trans (see Mutations in orf 1, orf 2, and orf 3 can be

Complemented in trans, this chapter).

To confirm that

they disrupt the same gene, both mutations were analyzed
for complementation by mating E.coli HBlOl
{R751) {pAC49) (pBR18) and E.coli HBlOl
(R751) (pAC18) (pBR49) with E.coli DW1030.

In these
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matings, no transfer of the pAC plasmids to DW1030 was
detected (table 6).

The failure of the mutations in pAC49

and pAC18 to complement one another supports the premise
that mbpC is a gene whose trans-acting protein product is
required for pLV22a mobilization when co-resident with
R751.

complementation analysis of mutations in mbpB.

The

coding region of the putative mobilization gene mbpB
extends from nt 415 to nt 1209, and codes for a
theoretical 29.4 kDa protein (fig. 12).

mbpB is

interrupted by the TnlOOO insertion mutations of 3
plasmids, pAC38 (nt 478), pAC39 (nt 535) and pAC7 (nt 927)
(fig. 12).

All 3 are Mob-, but can be mobilized when

wild-type pLV22a is present in trans (see Mutations in orf

1. ort 2. and ort 3 can be complemented in trans, this
chapter).

To confirm that they disrupt mbpB, these

mutations were analyzed for complementation by performing
the following filter matings: E. coli HBl0l
{R751) (pAC38) (pBR39), HBl0l (R751) {pAC38) (pBR7), HBl0l
(R751) (pAC39) (pBR38), HB101 (R751) (pAC39) (pBR7), HBl0l
(R751) (pAC7) {pBR38) and HBl0l (R751) (pAC7) (pBR39) mated
with E.coli DW1030.

In each case, no mobilization of a

pAC plasmid to DW1030 was observed (table 6).

Therefore,

the mutations of pAC38, pAC39 and pAC7 cannot complement
one another, demonstrating that the ORF they disrupt,
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Table 6.--complementation analyses of pLV22a Tn1000 mutants in E.
coli
Mobilization
genotype

complementing
Plasmid a

Mobilized
Plasmid a

Mean frequency of
mobilization b
(± SEM)

Wild-type
3.2 (±0.4)

pTJ5a

X 10- 3

pACYC184

<1.0

X 10- 5

pBR49 (mbpC-)

pAC18 (mbpC-)

<1.0

5
X 10-

pBR18 (mbpC-)

pAC49 (mbpC-)

<1.0

5
X 10-

(mbpB-)

pAC38 (mbpB-)

<1.0

X 10- 5

(mbpB-)

<1.0

X 10- 5

pAC39 (mbpB-)

<1.0

X 10- 5

mbpC (orf 3)

mbpB (orf 2)

pBR7

pBR38 (mbpB-)
pBR7

(mbpB-)

pAC7

pBR39 (mbpB-)

pAC7

(mbpB-)

<1.0

X 10- 5

pBR38 (mbpB-)

pAC39 (mbpB-)

<1.0

X 10- 5

pBR39 (mbpB-)

pAC38 (mbpB-)

<1.0

X 10- 5

pBR18 (mbpC-)

pAC39 (mbpB-)

2.5 (±1.4)

3
X 10-

pBR39 (mbpB-)

pAC18 (mbpC-)

4.7 (±2. 0)

X 10- 3

pBR67 (mbpA-)

pAC39 (mbpB-)

1. 1( ±0.4)

X 10- 3

pBR39 (mbpB-)

pAC67 (mbpA-)

9.3 (±5.8)

5
X 10-

pBR67 (mbpA-)

pAC18 (mbpC-)

1.9 (±0.8)

X 10- 3

pBR18 (mbpC-)

pAC67 (mbpA-)

2.2 (±1.3)

X 10- 4

mbpA (orf 1)

Notes: Plasmids were mobilized from E. coli HBl0l, containing R751
and a complementing plasmid where indicated, to E. coli DW1030.
See figure 13 for insertion mutation sites within mbpA, mbpB, and
(The number of each pBR and pAC plasmid corresponds to the
mutation contained within each plasmid.)
a

mbpC.

Mobilization frequency is defined as the number of plasmid
transconjugants / number of R751 transconjugants in the same mating
(N=3). 1x10-s defines the limit of detection.

b
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mbpB, produces a trans-acting product required for pLV22a
mobilization.
A Tn1000 insertion mutation in an upstream gene of an
operon will theoretically stop the expression of
downstream genes in that operon as well.
downstream genes is known as polarity (5).

This effect on
Thus, the

TnlOOO insertion mutations that disrupt mbpB could also be
polar on mbpC, if they constitute an operon (fig. 13).

To

determine whether mbpB and mbpC are part of an operon, the
Tn1000 insertion mutants pAC39 (mbpB) and pAC18 (mbpC)
were paired with the mutants pBR18 (mbpC) and pBR39
(mbpB), respectively, in the following matings: E. coli
HB101 (R751) (pAC39) (pBR18) and HBlOl (R751) (pAC18) (pBR39)
mated with E.coli DW1030.

pBR18 fully complemented

pAC39, and pBR39 fully complemented pAC18, demonstrating
that mbpB and mbpC are independently promoted genes, and
are not part of an operon (table 6).

complementation analysis of a mutation in

mb.pA..

The

coding region of the putative mobilization gene mbpA
extends from nt 119 to nt 418, and codes for a theoretical
11.7 kDa protein (fig. 12).

mbpA is interrupted by the

Tn1000 insertion mutation of pAC67 (nt 317). pAC67 is
Mob-, but can be mobilized when wild-type pLV22a is
present in trans (see Mutations in orf 1. ort 2, and orf 3
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can be complemented in trans, this chapter).

since mbpA

is the only major ORF disturbed by the mutation of pAC67,
and because it can be complemented by wild-type pLV22a in
trans, we conclude that mbpA is a gene whose trans-acting
product is required for pLV22a mobilization.
To test whether mbpA and mbpB are part of an operon,
the following E.coli strains were filter-mated with E.

coli DW1030: HB101 (R751) (pAC67) (pBR39) and HBl0l
(R751) (pAC39) (pBR67).

Similarly, to test whether mbpA and

mbpC are part of an operon, the following strains were
also mated with E.coli DW1030: HBl0l (R751) (pAC67) (pBR18)
and HBl0l (R751) (pAC18) (pBR67).

pBR67 (mbpA) was able to

fully complement the mutants pAC39 (mbpB) and pAC18
(mbpC). However, in the reverse experiments, pBR39 (mbpB)
and pBR18 (mbpC) only partially restored mobility to the
mutant plasmid, pAC67 (mbpA)

(table 6).

pBR39 and pBR18

should produce normal levels of MbpA, since their
mutations are well downstream of mbpA.

We therefore

reasoned that the partial complementation of pAC67 was due
to the TnlOOO insertion within mbpA of pAC67 itself (see
following section).

We concluded, however, that mbpB and

mbpC do not form an operon with mbpA, since pBR67 fully
complemented mutants of mbpB (pAC39) and mbpC (pAClS).
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Localization of a cis-acting Region Reguired for the
Mobilization of pLV22a
Complementation analysis of pAC67, a TnlOOO insertion
mutant of mbpA, found that while pAC67 could restore
mobility in trans to mutants of the downstream genes mbpB
and mbpC, these same mutant plasmids could only partially
restore mobility to pAC67 (see

a Mutation in mbpA,

complementation Analysis of

this chapter).

These data were

somewhat puzzling upon initial examination.

However,

further analysis suggested that the TnlOOO insertion of
pAC67 not only disrupts the trans-acting component
required for mobilization, mbpA, but might also interfere
with a cis-acting component of mobilization, the oriT (for
more on the oriT, see
Chapter 2.)

Horizontal Gene Transfer Factors,

When this region of DNA was analyzed for the

presence of grouped direct and/or inverted repeats
(DNASIS, version 3.00, Hitachi Software Engineering Co.),
we identified 2 sets of adjacent imperfect inverted
repeats that are 14 bp (nt 234 - nt 260) and 9 bp (nt 267
- nt 292) in size (fig. 12).

Inverted repeats have been

previously identified in the oriT sequences of several
transferable plasmids, including pBFTMlO and RP4
(41,68,126).

Their presence within mbpA supported our

hypothesis that the mutation of pAC67 interferes with a
cis-acting oriT that is located within the coding region
of the gene.
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To test this hypothesis, the pLV22a 1.5 kb
mobilization region, from which the first 32 bp of the

mbpA coding region and upstream promoter sequence had been
deleted (nt 1 - nt 150, fig. 12), was cloned into the Mobvector pACYC184.

This construct, pTJ12, was then tested

for mobilization by filter mating E.coli HBlOl
(R751) (pTJ12) with E.coli DW1030.

As expected, pTJ12 was

found to be Mob-, due to the partial deletion of the
mobilization gene, mbpA (table 7).

Table 7.--Complementation analysis of the pLV22a oriT region
Complementing
Plasmid

Mobilized Plasmid

Mean frequency of
mobilization a
( ± SEM)

NA

pTJGXB

pB22a

pACYC184

<1.0

None

pTJ12

<1.0

pTJS

pTJ12

<1.0

pB22a

pTJ347

4.1 (±0.S) X 10- 3

pB22a

pTJ437

9.4 (±2.6) X 10- 3

7.5 (±2.8) X 10~

Notes: Plasmids were mobilized from E.coli HBl0l, containing R751
and a complementing plasmid, to E.coli DW1030. l':ffi = not applicable.
a Mobilization frequency is defined as the number of plasmid
transconjugants / number of R751 transconjugants in the same mating
(N=3).
lXl0~ defines the limit of detection.

However, when wild-type pLV22a (pTJ8) was provided in

trans (HBlOl (R751) (pTJ8) (pTJ12) X DW1030) pTJ12 remained
mobilization-deficient (table 7).

Since the mutation of

pTJ12 could not be complemented by wild-type pLV22a in
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trans, we concluded that the region deleted in pTJ12
contains all or part of the cis-acting component required
for mobilization, the oriT.

cloning the pLv22a oriT
We used the polymerase chain reaction (£CE) to clone
the putative cis-acting oriT of pLV22a.
fragment (nt 44 - nt 390) and a 437

A 347 bp PCR

bp PCR fragment (nt

44 - nt 480), both containing the putative oriT region,
were cloned into the Mob- vector pACYC184, creating pTJ347
and pTJ437, respectively.

pTJ347 and pTJ437 were tested

for mobilization when co-resident with R751 and with wildtype pLV22a (pB22a) in trans, by mating the following
strains with E. coli DW1030: E.coli HBl0l
(R751) (pB22a) (pTJ347) and HBl0l (R751) (pB22a) (pTJ437).

In

these matings, both pTJ347 and pTJ437 were found to be
fully mobilizable, relative to wild-type pLV22a in pTJ6XB
(table 7).

To ensure that homologous recombination

between the cloned fragments of pTJ347/pTJ437 and the
mobilization-proficient pB22a had not occurred, 5 samples
of transconjugant plasmid DNA from each of these matings
were analyzed by restriction endonuclease digestion.

As

expected (both HBlOl and DW1030 are recA mutant strains),
no alterations were observed in the digestion patterns of
mobilized pTJ347 and pTJ437 (data not shown).

These data

indicated that pTJ347 and pTJ437 were most likely

90

mobilized in trans when co-resident with wild-type pLV22a
(and R751), and therefore contain the pLV22a oriT.

CHAPTER 5
SUMMARY & DISCUSSION

The objective of this dissertation project was to
isolate and characterize a novel conjugative (i.e.,
transferable by a conjugation-type mechanism) B. fragilis
factor.

By describing pLV22a and its mobilization region,

both here and elsewhere (62), this aim has been achieved.
The experiments performed in the project may be divided
into 5 principal groups:

I.

The capture of pLV22a by the transfer-deficient

;Plasmid pGAT400•BglII in an experiment designed to
/

investigate transfer factors present in the B.

fragilis strain LV22.
II.

The determination that pLV22a possessed a

mobilization region which functioned in both B.

fragilis and E.coli.
III. The localization of the pLV22a mobilization
region by the use of TnlOOO insertion mutagenesis,
and the subsequent determination of the mobilization
region DNA sequence.

Computerized analysis of this

sequence identified 5 major open reading frames
91
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(ORFs), all of which were potentially required for
mobilization in E.coli.
IV.

The use of complementation analysis to

demonstrate that the 3 "top strand" ORFs, designated
mbpA, mbpB and mbpC, produce trans-acting products

which are required for transfer in E. coli.

v.

The cloning of a cis-acting element located

within mbpA that is required for transfer in E.coli,
and which probably represents the pLV22a origin of
transfer oriT.

A discussion of the findings from each group of
experiments follows.

capture of pLV22a by pGAT400•BglII in B. thetaiotaomicron
BT22,47
In a search for novel Bacteroides conjugative
transfer factors, the Bacteroides-E. coli Tra- shuttle
plasmid pGAT400•BglII captured a 4.2 kb plasmid, pLV22a,
in a mating between B. thetaiotaomicron BT22.47
(pGAT400•BglII) and E.coli HBl0l.

From this mating, 2

transconjugants were found to contain
pGAT400•BglII::pLV22a fusions, designated pTJ47-1 and
pTJ47-3.

We hypothesized that pTJ47-1 and pTJ47-3 had

been formed in the donor, BT22.47, and that pLV22a
conferred transferability to the fusion plasmids, enabling
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them to transfer to HBlOl.

The donor, BT22.47, was itself

a product of a conjugative mating between a clinical
isolate, B. fragilis LV22, and a laboratory reference
strain, B. thetaiotaomicron BT4001.

We used high-

stringency Southern hybridization analysis to determine
that pLV22a was present in BT22.47, and 1 parent, LV22,
but not in the other parent, BT4001 (fig. 10).

The fact

that pLV22a had transferred from LV22 to BT4001, (giving
BT22.47), provided additional evidence that the plasmid
possessed conjugative properties.
pLV22a was captured by inverse transposition of
Tn4400,

the resident transposon of pGAT400•BglII.

Tn4400

is comprised of a core antibiotic resistance region which
is flanked by 2 mobile DNA sequences, 1S4400 left and
IS4400ti~c,

(81).

in a directly repeated orientation (fig. 1)

Restriction-endonuclease mapping and DNA sequencing

of the pLV22a-pGAT400•BglII junctions determined that all
core Tn4400 DNA internal to IS4400 1 eft and IS4400right had
been replaced by pLV22a DNA.

These data indicated that

pLV22a had been acquired by 1S4400-driven inverse
transposition events, in which the inward-facing IS ends
functioned to delete the core DNA and simultaneously
acquire pLV22a.

While Tn4400 inverse transposition in E.

coli has previously been reported (81), this is the first
known instance of inverse transposition in Bacteroides.
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In the mating that produced pTJ47-l and pTJ47-3, 2
other types of pGAT400•BglII transfer were also noted
(figs. 6 and 7):

(s) transfers resulting in the deletion

of Tn4400 from pGAT400•BglII, and (h) transfers of
unaltered pGAT400•BglII.

Since both pTJ47-l and pTJ47-3

have proven to be extremely stable in E.coli, the
possibility exists that pGAT400•BglII may have in some
instances been transferred by a Bacteroides factor other
than pLV22a hypothetically present in the donor, BT22.47.
Type g products could have been produced if the putative
BT22.47 transfer factor was integrated into pGAT400•BglII
by Tn4400, where it directed transfer of the cointegrate
into E. coli, and was then deleted due to an instability
of Bacteroides DNA in E. coli.

Such instability of

Bacteroides transfer factors in E.coli has been noted
elsewhere (102,105).

Alternatively, type

h products may

have been the result of pGAT400•BglII transfer in trans by
a putative BT22.47 transfer factor.

(This putative factor

may have been the LV22 Trans Factor, the original subject
of this study.

see Description of the Transfer Mechanisms

of the B. fragilis strain LV22, Chapter 4.)

The existence

of additional transfer factors in BT22.47, however,
remains to be determined.
We had thus isolated a 4.2 kb plasmid, pLV22a, from

B. fragilis LV22 that displayed indirect evidence of
conjugative transfer in Bacteroides.

Our next objective
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was to more exactly determine the nature of pLV22a
transfer.

characterization of the conjugative Transfer Properties of
pLV22a
pLV22a was identified as part of the Tra+ fusion
plasmids pTJ47-1 and pTJ47-3, and we hypothesized that the
transferability of the fusions was related to the presence
of pLV22a present in cis.

We found that pLV22a was indeed

transferable, both in Bacteroides and in E.coli.

In

Bacteroides, pLV22a, as part of pTJl0, transferred at a
frequency of 7.1 X 10- 9 from the laboratory reference
strain B. fragilis TM4000 (table 4).

This finding is near

our limit of detection, and is similar to that of pBFTMl0
and Tn4399, which both transfer from TM4000 at very low
frequency (41,42).
We questioned what effect a Tet Element would have on
pLV22a transfer in B. fragilis, since Tet Elements
increase the transfer frequencies of the Bacteroides
plasmids pBFTMl0 and pBS-51, and the conjugative
transposon Tn4399 by 1-2.5 orders of magnitude (42,104).
Tet Elements are Bacteroides-specific, conjugal (i.e.,
self-transferable) factors (70- -200 kb) that exist on the
chromosome of their host and express tetracycline, and
sometimes also erythromycin, resistances (4,102).

We

found that pLV22a transfer was increased by 3.5 orders of
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magnitude, to 1.5 X 10- 5 , from B. fragilis TM4.23, a Tet
Element+ isogeneic strain of TM4000 (table 4).
Notably, Bacteroides transfer factors such as pBFTMlO
and Tn4399 are conjugatively transferred in E.coli when
co-resident with the conjugal IncPB plasmid R751 (i.e.,
they are mobilized) (59,104).

pLV22a, as part of the

original fusion plasmids pTJ47-1 and pTJ47-3, is also
mobilized from E.coli when co-resident with R751, at
frequencies similar to pBFTMlO and Tn4399 (table 3).

To

ensure that the parental plasmid of pTJ47-1 and pTJ47-3,
pGAT400•BglII, is not required for pLV22a mobilization,
pLV22a was cloned into the Mob- vector pACYC184, giving
pTJ5a and pTJ6.

pTJ5a and pTJ6 were mobilized at

frequencies equal to or greater than the mobilization
frequencies of pTJ47-1 and pTJ47-3, thus demonstrating
that pGAT400•BglII is not required for pLV22a mobilization
in E.coli (table 3).
mobiltz_e_d
-.

_at_a

We also found that pTJ6 was

lligher freq_\lE!nc.y tJgi..rr.w~r-~__p_'l\J5a, -·~·~--pTJ47-1

and pTJ47-3 (table 3).

. "'"·-----.-

The reason for this increase in

mobilization frequency is unknown, but may be related to
the way in which pTJ5a and pTJ6 were constructed: in
pTJ5a, pLV22a is inserted into the chloramphenicol
resistance gene of pACYC184, while pTJ6 contains pLV22a in
the tetracycline resistance gene of pACYC184 (See Plasmid

constructions, Chapter 3.)

97
The mechanism by which Bacteroides Tet Elements
increase the transfer of pLV22a and other co-resident

Bacteroides transfer factors is unclear, but may be
related to the way in which these same plasmids are
mobilized in E. coli when co-resident with R751.
family Enterobacteriaceae, of which

In the

E. coli is a member,

2 major groups of naturally occurring plasmids exist that
transfer by conjugative mechanisms.

The first group,

typified by RP4, R751, and F, is comprised of large,
conjugal plasmids (50- >100 kb) that encode virtually all
of the many functions needed for their own transfer.
Plasmids of the second group, such as RSF1010 {23) and
ColEl {10), are smaller than conjugal plasmids {~10 kb),
do not encode all functions required for transfer, and are
thus not self-transferable.

However, they do encode 2

components that have been found to be essential for
conjugative transfer:

(g) a cis-acting origin of transfer

(oriT), the site at which one strand of DNA is nicked in a
specific manner in preparation for transfer into the
recipient cell,

{10,24), and (b) a limited number of

trans-acting proteins that recognize, and then nick, their
cognate oriT {8,10,49).

Because plasmids of the second

group contain these 2 elements, they are able to initiate
DNA processing at oriT, and are conjugatively mobilized to
a recipient cell when co-resident with certain conjugal
plasmids.

We and others

infer that the conjugal plasmid
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supplies the additional, more generalized transfer
functions not encoded by the mobilized plasmid (123).
The 2-step model of Enterobacteriaceae plasmid
mobilization may serve to explain the increased transfer
of pLV22a, pBFTMlO and Tn4399 that is observed when they
are co-resident with a conjugal Tet Element in B.
fragilis, and also their mobilization in E.coli, when co-

resident with R751.

Both pBFTMlO and Tn4399 resemble

mobilizable plasmids from the Enterobacteriaceae family in
size (14.6 kb and 9.6 kb, respectively) and in the limited
number of transfer functions they encode (i.e., an oriT
and 2 transfer proteins involved in binding and nicking at
their cognate origins of transfer) (41,59,60) (D.W. Hecht,
personal communication).

pLV22a is also small (4.2 kb),

and encodes 3 proteins and an oriT required for
mobilization.

It is thus possible that pLV22a, Tn4399 and

pBFTMlO encode only the functions required for nicking 1
strand of DNA at their cognate oriT, while the other, more
generalized transfer functions required to complete
tr-ans.fer are provided by Tet Elements in Bacteroides and
by R751 in E.coli.

It is important to note that while

pLV22a, pBFTMlO, and Tn4399 all conjugatively transfer in
both E.coli and B. fragilis, only pBFTMlO has been shown
to use the same transfer genes in both species (41).
The finding that pLV22a was mobilizable in E. coli
when co-resident with R751 was: fortuitous,, since the use
,

_;
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of this species allowed us to apply molecular methods not
available in Bacteroides.

Genetic exchange between

Bacteroides and E.coli may also have a physiologic basis
since:

(a) Bacteroides plasmids can transfer at least as

efficiently from Bacteroides to E.coli as from

Bacteroides to Bacteroides (41).

(We regularly use E.

coli as a recipient in conjugative matings from
Bacteroides.)

(b) Plasmids that can transfer in E. coli,

such as R751, can also transfer to Bacteroides (103).

(~)

Bacteroides and E. coli flourish together in their natural
habitat, the mammalian gut, and are frequently co-isolated
from intra-abdominal abscesses {See
2).

Epidemiology, Chapter

In spite of these findings, conjugative plasmids

alone do not appear to be capable of efficiently
transferring genetic information between Bacteroides and

Escherichia, since plasmids from 1 genus are not
maintained in the other genus, and most genes from 1 genus
are not expressed in the other (35,47,103,105).

However,

transposable elements such as Tn4400 and Tn4351 can
transpose in both E.coli and Bacteroides {103,105),
acquire new DNA by inverse transposition (81, this study),
and have promoters that can drive expression of newlyacquired genes in both genera (79).

Conjugative plasmids

could thus act together with transposable elements to
successfully exchange genetic information between

Bacteroides and Escherichia.

In this model of inter-genus
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genetic exchange, the transposon would acquire, express
and mobilize genes within the cell, while the conjugative
plasmid would serve as an intercellular carrier of a
transposon and its genetic information.

Localization and DNA seguence Analysis of the pLv22a
Mobilization Region
After determining that pLV22a possessed a conjugative
mobilization region, we created a library of pLV22a
insertion mutants with Tn1000.

By screening the library

for mutants that were no longer mobilizable in E.coli,
and then mapping the positions of Tn1000 in those mutants,
we identified a 1.5 kb region required for mobilization.
We then used these same Mob- mutants, together with
outward-facing primers to both ends of TnlOOO, to
determine the nucleic acid sequence of the pLV22a
mobilization region (fig. 12).
While mapping mutant positions in pLV22a, a 1.0 kb
region of pLV22a was identified that was resistant to
Tn1000 insertion (fig. 11).

This region is not required

for mobilization in E.coli, since it is not present in
the fully mobilizable plasmid pTJ6XB (table 3}; however,
the region could be involved in pLV22a transfer in
Bacteroides.

Computerized DNA sequence analysis (DNASIS,

Version 3.00 for IBM compatible computers, Hitachi
Software Corp.) of the 1.5 kb pLV22a mobilization region
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identified 3 ORFs of greater than 10 kDa size in the "top"
strand, orf 1, orf 2 and orf 3, and 2 major ORFs, orf 4
and orf 5, in the "bottom" strand.

TnlOOO insertions into

orf 1, orf 2 and orf 3 resulted in Mob- phenotypes,
implying that all 3 are required for mobilization in E.
coli (fig. 13).

Due to the nested architecture of orf 4

and orf 5 within orf 2, no conclusions could be drawn from
Tn1000 mutagenesis data concerning the necessity of orf 4
and orf 5 for mobilization (fig. 13).

orf 1 and orf 2

overlap by 4 bp, orf 2 and orf 3 overlap by 44 bp, and orf
5 overlaps orf 4 by 326 bp (fig. 12 and fig. 13).

The

derived protein products of orf 1, orf 2, orf 3, orf 4,
and orf 5 are 11.7 kDa, 29.4 kDa, 17.6 kDa, 18.9 kDa and
13.4 kDa in size, respectively, based upon the first
methionine codon in each ORF (fig. 12).

While relatively

small, these derived protein sizes are similar to the DNA
processing proteins of: Tn4399, MocA (36.4 kDa) and MocB
(16.4 kDa); pBFTMl0, BtgA (23.2 kDa) and BtgB (33.8 kDa);
ColEl, MbeB (17 kDa), MbeC (12 kDa) and MbeD (9 kDa)
(10,41,59).

We had now experimentally identified the 1.5 kb
region of pLV22a required for mobilization, sequenced this
region, and identified 5 major ORF's.

Our next

experiments were designed to test whether orf 1, orf 2,
and orf 3 are required for pLV22a mobilization in E. coli
when co-resident with R751.
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Identification and Characterization of the pLv22a Genes
Reguired for Mobilization in E, coli
We used complementation analysis to confirm that orf
1, orf 2 and orf 3 produce trans-acting products that are
required for mobilization.

Because orf 4 and orf 5 are

located entirely within orf 2, complementation analysis
could not be used to ascertain their role in mobilization
(fig 13).

We established that mutations in the

mobilization region clearly fell into 1 of 3
complementation groups: mutations in orf 1; mutations in
orf 2; and mutations in orf 3 (table 6).

That each

complementation group contains mutations in only 1 major
top strand ORF (i.e., orf 1, orf 2 or orf 3), and that no
instances of Tnl000-induced polarity on downstream ORF's
were seen, strongly argues that each ORF is an
independently promoted gene whose trans-acting product is
required for mobilization.

Based on these data, we

renamed orf 1, orf 2 and orf 3 mbpA, mbpB, and mbpC,
respectively.
Promoter and ribosomal binding site consensus
sequences have not as yet been identified in Bacteroides.
However, since pLV22a is mobilized in E.coli, we analyzed
mbpA, mbpB, mbpC, orf 4, and orf 5 for the presence of the

major, E. coli cr70 promoter, and for Shine-Dalgarno
ribosomal binding sites.

No strong homology to either the

-10/-35 promoter or Shine-Dalgarno consensus sequences was
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observed.

If the expression of mbpA, mbpB, and mbpC is

necessary for transfer in Bacteroides as well as in E.
coli, their promoters and ribosomal binding sites may

contain customized sequences that are recognized in both
E.coli and in Bacteroides; this could account for our

inability to identify E.coli transcription/translation
signals in mbpA, mbpB, and mbpC, as well as in orf 4 and
orf 5.

DNA sequence analysis detected 2 additional
characteristics of pTJ47-1 and pTJ47-3, the original
pLV22a fusion plasmids, that were a result of
pGAT400•BglII insertion into pLV22a at 2 different sites.
In pTJ47-1, the mbpA coding region begins only 19 bp
distal from IS4400 1 eft of pGAT400•BglII (figs. 12, 13).
Thus, the mbpA promoter would appear to be interrupted in
this clone.

We speculate that mbpA may be promoted by an

outward facing promoter potentially present in IS4400 left.
(IS4400 is not known to have such promoters.

However,

outward facing promoters active in E.coli have been
identified in a closely related insertion element, IS4351
(79).)

In pTJ47-3, mbpA contains its native upstream

sequence, and is thus probably promoted by its own
promoter.

The fact that no significant difference was

noted in the mobilization frequencies of pTJ47-1 and
pTJ47-3 (table 3) could indicate that the mbpA native
promoter is of similar strength to the putative IS4400
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promoter, that MbpA is not a limiting factor in plasmid
mobilization efficiency, or both.
Sequence analysis also discovered that pTJ47-3
contains an interruption of mbpC 7 nucleotides upstream of
its translational stop codon (fig. 12).

The amino acids

encoded by these codons do not however appear to be
necessary for mobilization, since pTJ47-3 is fully
mobilizable respective to pTJ47-1, in which mbpC is
intact.
Several lines of evidence suggest that MbpB is the
DNA relaxing enzyme, or relaxase, of pLV22a.

(Relaxases

are those enzymes that specifically nick 1 strand of DNA
at a cognate oriT sequence in preparation for conjugative
transfer.

For more on relaxases, see Horizontal Gene

Transfer Factors, Chapter 2.)

The BestFit program of the

Genetics Computer Group package {Version 8.0) was used to
compare MbpB with the transfer proteins of pBFTMl0 and
Tn4399.

BestFit, which makes an optimal alignment of the

best segment of similarity between two sequences,
identified a 73 aa segment of MocA, a proposed relaxase of
the B. fragilis conjugative transposon Tn4399, that is 38%
identical to a region of MbpB (fig. 14)

(59).

We also

identified a 6/10 match (8/10 when conservative
substitutions are included) between MbpB and a consensus
sequence that was derived from confirmed and putative
bacterial relaxases (68)

(fig. 14).

Both MbpB and MocA
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Fig. 14. Boxed sequences denotes conserved relaxase regions
according to Pansegrau and Lanka (see text for details). The number
to the left of each sequence denotes the position of the first
illustrated amino acid. A.... Alignment of putative relaxase regions
of MbpB (pLV22a) with other putative and known relaxase sequences.
The letter~ in the consensus sequence denotes neutral, hydrophobic,
amino acids.
Underlined letters in the MbpB sequence denote amino
acids identical to the consensus sequence, or amino acids which
represent conserved substitutions • .a.,_ Alignment of amino acid
sequences from MbpB and MocA (Tn4399), overlapping the putative
relaxase region as illustrated in Part A. Uppercase letters denote
identical amino acid residues, while lowercase letters denote
different residues.
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p
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carry the relaxase consensus sequence within their regions
that also display 38% identity (fig. 14).

While

imperfect, we consider the match between MbpB and the
consensus sequence to be significant, since Bacteroidaceae
are distantly related to the bacteria from which the
consensus is derived (122).

Notably, MbpB contains

conserved histidine residues in the consensus sequence at
positions 117 and 119.

These histidine residues are also

present in the consensus sequence of a known relaxase,
TraI of RP4 (aa 116 and 118), and are critical for nicking
at oriTRP 4 (fig. 14) (70).

The homology between MocA and

MbpB around the relaxase consensus sequence suggests that
these proteins, from otherwise very different transfer
factors, may share a common ancestral gene.

In contrast,

BestFit did not identify significant homology between MbpB
and the transfer proteins of the B. fragilis plasmid
pBFTMl0, BtgA and BtgB, making a common predecessor for
these proteins less likely.
We also used FastA and TFastA of the Genetics
Computer Group package to compare mbpA, mbpB, mbpC, orf 4
and orf 5 to sequences in the GenBank/EMBL database.

Both

FastA and TFastA perform Pearson and Lipman searches for
similarity between a query sequence and a group of
database sequences.

FastA analyzes both strands of a DNA

sequence, while TFastA analyzes all 6 open reading frames
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derived from a DNA sequence.

No significant homologies

between pLV22a and databank sequences were identified.
studies are currently under way to investigate whether
MbpB is indeed a relaxase that is active in nicking at
oriTpL~2 a, and to discover what roles MbpA and MbpC may

play in the process.

cloning a cis-acting Region Required for Mobilization
Complementation analysis of mbpA determined that
TnlOOO insertion mutation 67, which is located within mbpA
at nt 317, was only partially complemented when MbpA was
provided in trans (see table 6, Mobilization genotype

mbJ;lA, mobilization of pAC67 by complementing plasmids
pBR39 and pBR18).

This suggested to us that the

relatively large transposon insertion of mutation 67 was
disrupting both mbpA and the cis-acting oriTpL~2 a.

Using

computer analysis, we also identified 2 imperfect inverted
repeats within mbpA, the first spanning from nt 234 - nt
260, the other from nt 267 - nt 292 (fig. 12).

The

finding of inverted repeats near mutation 67 supported the
idea that the pLV22a oriT is located within mbpA, since
inverted repeats have been previously identified in other
bacterial origins of transfer (41,60,126).

To test this

hypothesis, we PCR-amplified a 347 bp region (nt 44 to nt
390) around mutation 67, and cloned the fragment into the
Mob-

vector pACYC184 (fig. 12).

We found that this
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construct, pTJ347, was fully mobilizable from E. coli when
co-resident with R751 and wild-type pLV22a on a compatible
plasmid (table 7).

This result indicated that the 347 bp

PCR fragment, from within mbpA, contains the pLV22a oriT.
DNA sequence analysis of the fragment identified a region
that displays 66.7% homology to the 12 bp oriT/nick-site
consensus sequence of Pansegrau and Lanka (68):

pLV22a
Consensus:
G T A C
G T

T C

Bacteroidaceae are distantly related to the bacteria from
which this consensus is derived (122), and we therefore
consider the match, while imperfect, to nevertheless be
significant.

We have thus localized the pLV22a oriT to a

347 bp region that is located primarily within mbpA.

This

is not unique: the Tn4399 oriT also resides in a
mobilization gene, mocB {59).

Experiments to identify the

nick site within the 347 bp PCR fragment, using PCR cyclesequencing, are currently under way.

Potential Functions of the pLV22a Mobilization Proteins
While the genes required for pLV22a mobilization in
E. coli are known, the functions of their protein

products, MbpA, MbpB and Mbpc, are not.

We propose that

MbpA, MbpB and MbpC function to recognize and bind at
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oriTPL~2 a, and to then specifically nick 1 strand of DNA in

preparation for transfer.

This model, which is based upon

the relatively well characterized DNA processing systems
of conjugative plasmids found in bacteria of the family
Enterobacteriaceae, may also apply to Bacteroides transfer
factors other than pLV22a.
factors, see Chapter 2,

(For a review of Bacteroides

Horizontal Transfer Factors.)

Among the Enterobacteriaceae, 3 plasmids whose DNA
processing mechanisms have been extensively reported on
are ColEl, RSFl0l0, and RP4.
The 6.6 kb plasmid ColEl encodes 4 proteins, MbeA (60
kDa), MbeB (17 kDa), MbeC (12 kDa) and MbeD (9 kDa), which
are required for mobilization when co-resident with IncF,
Incl, IncP or IncW conjugal plasmids (10).

Helinski et

al. have determined that three mobilization proteins
(probably MbeA, MbeB and MbeC), form a relaxosome at the
ColEl oriT.

A 60 kDa relaxosome protein that is likely

MbeA becomes covalently linked to the 5' end of the nicked
DNA strand, and may act to chaperon this strand into the
recipient while protecting it from 5 1 exonucleases.

The

60 kDa protein may also re-circularize the strand in the
recipient (8,36,49).
RSF1010 is an 8.9 kb IncQ plasmid that is mobilized
when co-resident with conjugal plasmids of the Incia,
IncM, IncP and IncX groups.

RSFl0l0 encodes 3 relaxosome

proteins, MobA, MobB and MobC, that are required for
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mobilization in vivo (23).

MobA is a large (78 kDa),

multi-functional protein that recognizes a specific
sequence in oriTRsnoio, binds to the sequence, and then
nicks 1 strand of DNA within the oriT.

After nicking,

MobA covalently bonds to the 5' end of the broken DNA
strand, where it may act to recircularize the strand
following entry of the nucleoprotein complex into the
recipient (94,95). (MobA is unusual in that it is also
known as RepB, and functions as a primase in the
vegetative replication of RSFl0l0 (96).)

The second

relaxosome protein, MobB, increases the efficiency of in

vitro nicking at oriT by either stabilizing the relaxosome
complex, or by altering the local DNA topology (95).

The

third protein, Mobc, is a helicase that is brought into
the relaxosome by MobA, and may serve to melt the doublestranded DNA molecule prior to nicking (95).
While all the details of DNA processing in ColEl and
RSFl0l0 have not been elucidated, it is clear that each
encodes several proteins that function in the context of a
relaxosome to specifically nick 1 strand of DNA at a site
within their cognate oriT.

Perhaps the most well studied

DNA processing system is that of the IncP plasmid RP4.
RP4 is very different from ColEl and RSFl0l0, and also
pLV22a, in that it is much larger (60 kb), and is fully
self-transferable.

However, one way in which RP4

resembles ColEl and RSF1010 is that it too uses a
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relaxosome to specifically nick 1 strand of DNA at its
oriT prior to transfer.

In RP4 relaxosome formation, TraJ

first recognizes, and then binds, to the right half of a
19 bp inverted repeat sequence within the oriT (126).
TraI then recognizes a 6 bp sequence between the nick site
of oriT and the TraJ-binding site, and joins the TraJ-oriT
nucleoprotein complex (69).

TraH specifically interacts

with both TraI and TraJ, and is proposed to stabilize the
relaxosome (67), while TraK acts to enhance nicking at
oriT by locally altering the DNA superhelicity (29,127).

Once the relaxosome is formed, TraI cleaves a defined
strand of DNA at the nick site, after which TraI becomes
covalently attached to the 5' phosphoryl end (69).
MbpA, MbpB and MbpC may also function in a relaxosome
to nick 1 strand of DNA within oriTpL~2 a•

As discussed

above, MbpB appears to be the relaxase of pLV22a.

As the

relaxase, MbpB may both recognize and bind to a site
within oriTpL~2 a, and then nick 1 strand of DNA.

This is

similar to MobA of RSFlOlO, the relaxase which both
recognizes and binds to oriTRsnow, and then provides the
nicking function.

Alternatively, MbpB may require MbpA

and/or MbpC to first recognize and bind oriTpL~2 a before it
can enter the relaxosome/DNA complex (as is seen with
TraJ/TraI of RP4) (fig. 15).
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MbpA/MbpC
MbpB

.
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/
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IR 2

mbpA

Fig. 15. Model of potential nucleoprotein interactions at the oriT
of pLV22a.
IR 1 and IR 2 represent inverted repeats 1 and 2, as
found in figure 12. Dotted arrow represents potential covalent
bonding of an Mbp protein to the nicked strand of DNA at its 5' end.
Dashed horizontal lines represent double-stranded DNA. The position
of nic in this figure is hypothetical.
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MbpA, MbpB and MbpC may also:
(g)

possess helicase activity, which would serve to

melt the DNA prior to nicking, as does MobC in the
RSF1010 system;

(b)

act to stabilize the relaxosome complex, as is

seen with TraH of RP4;
(~)

alter the local DNA topography to facilitate

oriT recognition and binding by the relaxosome, as
does TraK of RP4;

(d)

covalently bond to the nicked strand of pLV22a

and then act to chaperon the strand into the
recipient.

Once in the recipient, the bound protein

may act to protect the strand from nuclease attack,
and participate in re-circularizing the DNA strand
prior to second-strand synthesis.

(Some of these

functions are thought to be fulfilled by MobA of
RSF1010 and MbeA of ColEl.)

As chaperon, the bound

pLV22a protein may also interact with transfer
proteins from the conjugal plasmid that assist in
transfer and re-circularization of the nicked strand,
and with bacterial proteins to assist in second
strand synthesis.

Experiments are currently being conducted in our
laboratory to test this model.
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